BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ostapowicz G. Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States. Ann Intern Med 2002;137:947. [DOI: 10.7326/0003-4819-137-12-200212170-00007] [Cited by in Crossref: 1426] [Cited by in F6Publishing: 1175] [Article Influence: 75.1] [Reference Citation Analysis]
Number Citing Articles
1 Fang WY, Abuduxikuer K, Shi P, Qiu YL, Zhao J, Li YC, Zhang XY, Wang NL, Xie XB, Lu Y, Knisely AS, Wang JS. Pediatric Wilson disease presenting as acute liver failure: Prognostic indices. World J Clin Cases 2021; 9(14): 3273-3286 [PMID: 34002136 DOI: 10.12998/wjcc.v9.i14.3273] [Reference Citation Analysis]
2 Parekh NK, Hynan LS, De Lemos J, Lee WM; Acute Liver Failure Study Group. Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure? Hepatology 2007;45:1489-95. [PMID: 17538968 DOI: 10.1002/hep.21640] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
3 Vitins AP, Kienhuis AS, Speksnijder EN, Roodbergen M, Luijten M, van der Ven LT. Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models. Arch Toxicol 2014;88:1573-88. [PMID: 24535564 DOI: 10.1007/s00204-014-1211-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
4 Vandriel SM, Ayoub MD, Ricciuto A, Hansen BE, Ling SC, Ng VL, Roberts EA, Kamath BM. Pediatric Wilson Disease Presenting as Acute Liver Failure: An Individual Patient Data Meta-analysis. Journal of Pediatric Gastroenterology & Nutrition 2020;71:e90-6. [DOI: 10.1097/mpg.0000000000002777] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fujiwara K, Yasui S, Yonemitsu Y, Arai M, Kanda T, Nakano M, Oda S, Yokosuka O. Fixed point observation of etiology of acute liver failure according to the novel Japanese diagnostic criteria. J Hepatobiliary Pancreat Sci 2015;22:225-9. [PMID: 25339364 DOI: 10.1002/jhbp.178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
6 Boudreau DM, Wirtz H, Von Korff M, Catz SL, St John J, Stang PE. A survey of adult awareness and use of medicine containing acetaminophen. Pharmacoepidemiol Drug Saf 2013;22:229-40. [PMID: 22890688 DOI: 10.1002/pds.3335] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
7 Joshi GP. Multimodal analgesia techniques for ambulatory surgery. Int Anesthesiol Clin 2005;43:197-204. [PMID: 15970757 DOI: 10.1097/01.aia.0000166336.69251.dd] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kwon H, Lee SH, Kim SE, Lee JH, Jee YK, Kang HR, Park BJ, Park JW, Hong CS. Spontaneously reported hepatic adverse drug events in Korea: multicenter study. J Korean Med Sci 2012;27:268-73. [PMID: 22379337 DOI: 10.3346/jkms.2012.27.3.268] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
9 Li Y, Yang X, Plummer R, Hayashi Y, Deng XS, Nie YZ, Taniguchi H. Human Pluripotent Stem Cell-Derived Hepatocyte-Like Cells and Organoids for Liver Disease and Therapy. Int J Mol Sci 2021;22:10471. [PMID: 34638810 DOI: 10.3390/ijms221910471] [Reference Citation Analysis]
10 Eapen J, Ayoola R, Subramanian RM. 'The efficacy of extracorporeal liver support with molecular adsorbent recirculating system in severe drug-induced liver injury'. Oxf Med Case Reports 2018;2018:omx077. [PMID: 29308212 DOI: 10.1093/omcr/omx077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Uetrecht J. Evaluation of Which Reactive Metabolite, If Any, Is Responsible for a Specific Idiosyncratic Reaction. Drug Metabolism Reviews 2008;38:745-53. [DOI: 10.1080/03602530600959615] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
12 Stevens RD, Nyquist PA. The systemic implications of aneurysmal subarachnoid hemorrhage. Journal of the Neurological Sciences 2007;261:143-56. [DOI: 10.1016/j.jns.2007.04.047] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
13 Nam EJ, Hayashida K, Aquino RS, Couchman JR, Kozar RA, Liu J, Park PW. Syndecan-1 limits the progression of liver injury and promotes liver repair in acetaminophen-induced liver injury in mice. Hepatology 2017;66:1601-15. [PMID: 28543100 DOI: 10.1002/hep.29265] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
14 Pamecha V, Vagadiya A, Sinha PK, Sandhyav R, Parthasarathy K, Sasturkar S, Mohapatra N, Choudhury A, Maiwal R, Khanna R, Alam S, Pandey CK, Sarin SK. Living Donor Liver Transplantation for Acute Liver Failure: Donor Safety and Recipient Outcome. Liver Transpl. 2019;25:1408-1421. [PMID: 30861306 DOI: 10.1002/lt.25445] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
15 Miyakawa K, Joshi N, Sullivan BP, Albee R, Brandenberger C, Jaeschke H, McGill MR, Scott MA, Ganey PE, Luyendyk JP, Roth RA. Platelets and protease-activated receptor-4 contribute to acetaminophen-induced liver injury in mice. Blood 2015;126:1835-43. [PMID: 26179083 DOI: 10.1182/blood-2014-09-598656] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
16 Ruan J, Gao H, Li N, Xue J, Chen J, Ke C, Ye Y, Fu PP, Zheng J, Wang J, Lin G. Blood Pyrrole-Protein Adducts--A Biomarker of Pyrrolizidine Alkaloid-Induced Liver Injury in Humans. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2015;33:404-21. [PMID: 26398275 DOI: 10.1080/10590501.2015.1096882] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 9.6] [Reference Citation Analysis]
17 Alonso EM. Acute liver failure in children: The role of defects in fatty acid oxidation. Hepatology 2005;41:696-9. [DOI: 10.1002/hep.20680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
18 Martinez-Cabriales SA, Shear NH, Gonzalez-Moreno EI. Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome. World J Clin Cases 2019; 7(6): 705-716 [PMID: 30968035 DOI: 10.12998/wjcc.v7.i6.705] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
19 Hou F, Zeng Z, Wang G. Hospital Admissions for Drug-Induced Liver Injury: Clinical Features, Therapy, and Outcomes. Cell Biochem Biophys 2012;64:77-83. [DOI: 10.1007/s12013-012-9373-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
20 Mandaliya H, Baghi P, Prawira A, George MK. A Rare Case of Paclitaxel and/or Trastuzumab Induced Acute Hepatic Necrosis. Case Rep Oncol Med 2015;2015:825603. [PMID: 26605100 DOI: 10.1155/2015/825603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
21 Weil JG, Bains C, Linke A, Clark DW, Stirnadel HA, Hunt CM. Background incidence of liver chemistry abnormalities in a clinical trial population without underlying liver disease. Regulatory Toxicology and Pharmacology 2008;52:85-8. [DOI: 10.1016/j.yrtph.2008.06.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
22 Yusuf D, Christy J, Owen D, Ho M, Li D, Fishman MJ. A case report of nifedipine-induced hepatitis with jaundice. BMC Res Notes. 2018;11:228. [PMID: 29615102 DOI: 10.1186/s13104-018-3322-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
23 Punzalan CS, Barry CT. Acute Liver Failure: Diagnosis and Management. J Intensive Care Med 2016;31:642-53. [PMID: 26446105 DOI: 10.1177/0885066615609271] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
24 Tolosa L, Jiménez N, Pérez G, Castell JV, Gómez-Lechón MJ, Donato MT. Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury. Arch Toxicol 2018;92:383-99. [PMID: 28762043 DOI: 10.1007/s00204-017-2036-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
25 Idilman R, Bektas M, Cinar K, Toruner M, Cerit ET, Doganay B, Erden E, Bozkaya H, Bahar K, Karayalcin S, Soykan I, Palabiyikoglu M, Cetinkaya H, Yurdaydin C, Dokmeci A, Ozden A. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience. J Clin Gastroenterol 2010;44:e128-32. [PMID: 20551776 DOI: 10.1097/MCG.0b013e3181c5e9cc] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
26 Cardoso FS, Marcelino P, Bagulho L, Karvellas CJ. Acute liver failure: An up-to-date approach. J Crit Care. 2017;39:25-30. [PMID: 28131021 DOI: 10.1016/j.jcrc.2017.01.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 8.8] [Reference Citation Analysis]
27 Xu P, Guo A, Xu J, Yao J, Chen H, Wang F, Zhu C. Evaluation of a combinational use of serum microRNAs as biomarkers for liver diseases. Clin Res Hepatol Gastroenterol 2017;41:254-61. [PMID: 28215541 DOI: 10.1016/j.clinre.2016.10.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 You S, Rong Y, Zhu B, Zhang A, Zang H, Liu H, Li D, Wan Z, Xin S. Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey. Hepatol Int. 2013;7:714-720. [PMID: 26201805 DOI: 10.1007/s12072-013-9424-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
29 Parks D, Lin X, Painter JL, Cheng J, Hunt CM, Spraggs CF, Nelson JJ, Curtis L, Menius JA, Lee KR. A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data: ONCOLOGY CLINICAL TRIALS HEPATOTOXICITY DATA. Pharmacoepidemiol Drug Saf 2013;22:571-8. [DOI: 10.1002/pds.3405] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
30 Kang SG, Park YM, Lee HJ, Yoon B. Duloxetine-induced liver injury in patients with major depressive disorder. Psychiatry Investig 2011;8:269-71. [PMID: 21994516 DOI: 10.4306/pi.2011.8.3.269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
31 Lo Re V 3rd, Carbonari DM, Forde KA, Goldberg D, Lewis JD, Haynes K, Leidl KB, Reddy RK, Roy J, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA. Validity of diagnostic codes and laboratory tests of liver dysfunction to identify acute liver failure events. Pharmacoepidemiol Drug Saf 2015;24:676-83. [PMID: 25866286 DOI: 10.1002/pds.3774] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
32 Holt M, Ju C. Drug-Induced Liver Injury. In: Uetrecht J, editor. Adverse Drug Reactions. Berlin: Springer Berlin Heidelberg; 2010. pp. 3-27. [DOI: 10.1007/978-3-642-00663-0_1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
33 Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55-68. [PMID: 19132805 DOI: 10.2165/00002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Foston TP, Carpentar D. Acute liver failure. Crit Care Nurs Clin North Am. 2010;22:395-402. [PMID: 20691389 DOI: 10.1016/j.ccell.2010.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
35 Bouwmeester MC, Bernal PN, Oosterhoff LA, van Wolferen ME, Lehmann V, Vermaas M, Buchholz MB, Peiffer QC, Malda J, van der Laan LJW, Kramer NI, Schneeberger K, Levato R, Spee B. Bioprinting of Human Liver-Derived Epithelial Organoids for Toxicity Studies. Macromol Biosci 2021;:e2100327. [PMID: 34559943 DOI: 10.1002/mabi.202100327] [Reference Citation Analysis]
36 Bartels S, Sivilotti M, Crosby D, Richard J. Are recommended doses of acetaminophen hepatotoxic for recently abstinent alcoholics? A randomized trial. Clinical Toxicology 2009;46:243-9. [DOI: 10.1080/15563650701447020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
37 Møller HJ, Grønbaek H, Schiødt FV, Holland-Fischer P, Schilsky M, Munoz S, Hassanein T, Lee WM. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol. 2007;47:671-676. [PMID: 17629586 DOI: 10.1016/j.jhep.2007.05.014] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 7.7] [Reference Citation Analysis]
38 Zimmerman JJ, Patat A, Parks V, Moirand R, Matschke K. Pharmacokinetics of sirolimus (rapamycin) in subjects with severe hepatic impairment. J Clin Pharmacol 2008;48:285-92. [PMID: 18218785 DOI: 10.1177/0091270007312902] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
39 Kleiner DE. Liver Injury Due to Drugs and Herbal Agents. Practical Hepatic Pathology: a Diagnostic Approach. Elsevier; 2018. pp. 327-70. [DOI: 10.1016/b978-0-323-42873-6.00023-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Zhu X, Uetrecht J. A novel T(H)17-type cell is rapidly increased in the liver in response to acetaminophen-induced liver injury: T(H)17 cells and the innate immune response. J Immunotoxicol 2013;10:287-91. [PMID: 23039944 DOI: 10.3109/1547691X.2012.724730] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
41 Court MH, Peter I, Hazarika S, Vasiadi M, Greenblatt DJ, Lee WM; Acute Liver Failure Study Group. Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure. Drug Metab Dispos 2014;42:28-32. [PMID: 24104197 DOI: 10.1124/dmd.113.053546] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
42 Lahdenperä A, Koivusalo AM, Vakkuri A, Höckerstedt K, Isoniemi H. Value of albumin dialysis therapy in severe liver insufficiency. Transpl Int 2005;17:717-23. [PMID: 15580335 DOI: 10.1007/s00147-004-0796-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
43 Ates M, Hatipoglu S, Dirican A, Isik B, Ince V, Yilmaz M, Aydin C, Ara C, Kayaalp C, Yilmaz S. Right-lobe living-donor liver transplantation in adult patients with acute liver failure. Transplant Proc 2013;45:1948-52. [PMID: 23769080 DOI: 10.1016/j.transproceed.2012.10.056] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
44 Wang YP, Shi B, Chen YX, Xu J, Jiang CF, Xie WF. Drug-induced liver disease: an 8-year study of patients from one gastroenterological department. Journal of Digestive Diseases 2009;10:195-200. [DOI: 10.1111/j.1751-2980.2009.00385.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
45 Tan EH, Low EXS, Dan YY, Tai BC. Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases. Liver Int 2018;38:742-53. [PMID: 29193566 DOI: 10.1111/liv.13646] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
46 Avigan MI. Regulatory Perspectives. Drug-Induced Liver Disease. Elsevier; 2013. pp. 689-712. [DOI: 10.1016/b978-0-12-387817-5.00038-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Sarganas G, Kreutz R, Garbe E. Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study. Br J Clin Pharmacol. 2015;79:988-999. [PMID: 25444550 DOI: 10.1111/bcp.12565] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 9.2] [Reference Citation Analysis]
48 Heo NY, Lim YS, An J, Ko SY, Oh HB. Multiplex polymerase chain reaction test for the diagnosis of acute viral hepatitis A. Clin Mol Hepatol 2012;18:397-403. [PMID: 23323256 DOI: 10.3350/cmh.2012.18.4.397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Yang S, Kuang G, Jiang R, Wu S, Zeng T, Wang Y, Xu F, Xiong L, Gong X, Wan J. Geniposide protected hepatocytes from acetaminophen hepatotoxicity by down-regulating CYP 2E1 expression and inhibiting TLR 4/NF-κB signaling pathway. International Immunopharmacology 2019;74:105625. [DOI: 10.1016/j.intimp.2019.05.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
50 Reuben A. The last gasp or Caveat cenans! Hepatology 2003;38:273-6. [DOI: 10.1002/hep.510380143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
51 Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman RK, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): Management of Acute Liver Failure. J Clin Exp Hepatol 2020;10:477-517. [PMID: 33029057 DOI: 10.1016/j.jceh.2020.04.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
52 Joshi GP. Multimodal Analgesia Techniques and Postoperative Rehabilitation. Anesthesiology Clinics of North America 2005;23:185-202. [DOI: 10.1016/j.atc.2004.11.010] [Cited by in Crossref: 130] [Cited by in F6Publishing: 110] [Article Influence: 8.1] [Reference Citation Analysis]
53 Yener S, Akarsu M, Karacanci C, Sengul B, Topalak O, Biberoglu K, Akpinar H. Wilson's disease with coexisting autoimmune hepatitis. Journal of Gastroenterology and Hepatology 2004;19:114-6. [DOI: 10.1111/j.1440-1746.2004.03254.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
54 Nephew L, Zia Z, Ghabril M, Orman E, Lammert C, Chalasani N. Black Adult Patients With Acute Liver Failure Are Sicker and More Likely to Undergo Liver Transplantation Than White Patients. Liver Transpl 2019;25:1634-41. [DOI: 10.1002/lt.25594] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 James LP. Acetaminophen. Drug-Induced Liver Disease. Elsevier; 2013. pp. 331-41. [DOI: 10.1016/b978-0-12-387817-5.00020-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Ekser B, Gridelli B, Tector AJ, Cooper DK. Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit? Transplantation. 2009;88:1041-1049. [PMID: 19898198 DOI: 10.1097/tp.0b013e3181ba0555] [Cited by in Crossref: 44] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
57 Hawton K, Simkin S, Deeks J, Cooper J, Johnston A, Waters K, Arundel M, Bernal W, Gunson B, Hudson M, Suri D, Simpson K. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ. 2004;329:1076. [PMID: 15516343 DOI: 10.1136/bmj.38253.572581.7c] [Cited by in Crossref: 155] [Cited by in F6Publishing: 48] [Article Influence: 9.1] [Reference Citation Analysis]
58 Hanish SI, Stein DM, Scalea JR, Essien EO, Thurman P, Hutson WR, Bartlett ST, Barth RN, Scalea TM. Molecular Adsorbent Recirculating System Effectively Replaces Hepatic Function in Severe Acute Liver Failure. Ann Surg. 2017;266:677-684. [PMID: 28692474 DOI: 10.1097/sla.0000000000002361] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
59 Schiødt FV, Chung RT, Schilsky ML, Hay JE, Christensen E, Lee WM. Outcome of acute liver failure in the elderly. Liver Transpl. 2009;15:1481-1487. [PMID: 19877205 DOI: 10.1002/lt.21865] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
60 Russmann S, Kullak-Ublick GA, Grattagliano I. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem 2009;16:3041-53. [PMID: 19689281 DOI: 10.2174/092986709788803097] [Cited by in Crossref: 231] [Cited by in F6Publishing: 201] [Article Influence: 19.3] [Reference Citation Analysis]
61 Abdallah MA, Abdalla A, Ellithi M, Abdalla AO, Cunningham AG, Yeddi A, Rajendiran G. Turmeric-Associated Liver Injury. Am J Ther 2020;27:e642-5. [PMID: 31283536 DOI: 10.1097/MJT.0000000000001025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Zhang YV, Fan S, Kellogg MD. Effect of hemolysis, icterus, and lipemia on three acetaminophen assays: Potential medical consequences of false positive results. Clinica Chimica Acta 2018;487:287-92. [DOI: 10.1016/j.cca.2018.10.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Kamat P, Kunde S, Vos M, Vats A, Gupta N, Heffron T, Romero R, Fortenberry JD. Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatr Crit Care Med 2012;13:e33-8. [PMID: 21263362 DOI: 10.1097/PCC.0b013e31820ac08f] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 3.4] [Reference Citation Analysis]
64 Sentürk E, Esen F, Ozcan PE, Rifai K, Pinarbaşi B, Cakar N, Telci L. The treatment of acute liver failure with fractionated plasma separation and adsorption system: Experience in 85 applications. J Clin Apher 2010;25:195-201. [PMID: 20818714 DOI: 10.1002/jca.20238] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
65 Chou JW, Bushel PR. Discernment of possible mechanisms of hepatotoxicity via biological processes over-represented by co-expressed genes. BMC Genomics 2009;10:272. [PMID: 19538742 DOI: 10.1186/1471-2164-10-272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
66 Paridaens A, Raevens S, Colle I, Bogaerts E, Vandewynckel Y, Verhelst X, Hoorens A, Grunsven LA, Van Vlierberghe H, Geerts A, Devisscher L. Combination of tauroursodeoxycholic acid and N‐acetylcysteine exceeds standard treatment for acetaminophen intoxication. Liver Int 2017;37:748-56. [DOI: 10.1111/liv.13261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
67 Paterson WG, Depew WT, Paré P, Petrunia D, Switzer C, Veldhuyzen van Zanten SJ, Daniels S; Canadian Association of Gastroenterology Wait Time Consensus Group. Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol 2006;20:411-23. [PMID: 16779459 DOI: 10.1155/2006/343686] [Cited by in Crossref: 61] [Cited by in F6Publishing: 79] [Article Influence: 4.1] [Reference Citation Analysis]
68 Le Minh K, Klemm K, Abshagen K, Eipel C, Menger MD, Vollmar B. Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice. Am J Pathol 2007;170:1954-63. [PMID: 17525263 DOI: 10.2353/ajpath.2007.061056] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
69 Grattagliano I, Bonfrate L, Diogo CV, Wang HH, Wang DQ, Portincasa P. Biochemical mechanisms in drug-induced liver injury: Certainties and doubts. World J Gastroenterol 2009; 15(39): 4865-4876 [PMID: 19842215 DOI: 10.3748/wjg.15.4865] [Cited by in CrossRef: 83] [Cited by in F6Publishing: 74] [Article Influence: 6.9] [Reference Citation Analysis]
70 Bacak SJ, Thornburg LL. Liver Failure in Pregnancy. Critical Care Clinics 2016;32:61-72. [DOI: 10.1016/j.ccc.2015.08.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
71 Urfi MK, Mujahid M, Rahman MA, Rahman MA. The Role of Tamarix gallica Leaves Extract in Liver Injury Induced by Rifampicin Plus Isoniazid in Sprague Dawley Rats. J Diet Suppl. 2018;15:24-33. [PMID: 28459346 DOI: 10.1080/19390211.2017.1310783] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
72 Thawley V. Acute Liver Injury and Failure. Vet Clin North Am Small Anim Pract 2017;47:617-30. [PMID: 28065578 DOI: 10.1016/j.cvsm.2016.11.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
73 Singh S, Hynan LS, Lee WM. Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure. Dig Dis Sci. 2013;58:1397-1402. [PMID: 23325162 DOI: 10.1007/s10620-012-2512-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
74 Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, Dhawan A, Rosenthal P, Rodriguez-Baez N, Murray KF, Horslen S, Martin MG, Lopez MJ, Soriano H, McGuire BM, Jonas MM, Yazigi N, Shepherd RW, Schwarz K, Lobritto S, Thomas DW, Lavine JE, Karpen S, Ng V, Kelly D, Simonds N, Hynan LS. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652-658. [PMID: 16737880 DOI: 10.1016/j.jpeds.2005.12.051] [Cited by in Crossref: 467] [Cited by in F6Publishing: 341] [Article Influence: 31.1] [Reference Citation Analysis]
75 Kumar BS, Chung BC, Kwon OS, Jung BH. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics. J Appl Toxicol 2012;32:505-20. [PMID: 22131085 DOI: 10.1002/jat.1746] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
76 Fahy BN, Guo T, Ghose R. Impact of hepatic malignancy on CYP3A4 gene expression. J Surg Res 2012;178:768-72. [PMID: 22763214 DOI: 10.1016/j.jss.2012.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
77 Fontana RJ, Seeff LB, Andrade RJ, Björnsson E, Day CP, Serrano J, Hoofnagle JH. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology 2010;52:730-42. [PMID: 20564754 DOI: 10.1002/hep.23696] [Cited by in Crossref: 191] [Cited by in F6Publishing: 174] [Article Influence: 17.4] [Reference Citation Analysis]
78 Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology. 2008;48:1577-1585. [PMID: 18925633 DOI: 10.1002/hep.22493] [Cited by in Crossref: 133] [Cited by in F6Publishing: 106] [Article Influence: 10.2] [Reference Citation Analysis]
79 Wong A, Sivilotti MLA, Gunja N, McNulty R, Graudins A. Accuracy of the paracetamol-aminotransferase product to predict hepatotoxicity in paracetamol overdose treated with a 2-bag acetylcysteine regimen. Clin Toxicol (Phila) 2018;56:182-8. [PMID: 28756679 DOI: 10.1080/15563650.2017.1355058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
80 Hadi M, Westra IM, Starokozhko V, Dragovic S, Merema MT, Groothuis GM. Human precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury. Chem Res Toxicol. 2013;26:710-720. [PMID: 23565644 DOI: 10.1021/tx300519p] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
81 Bunchorntavakul C, Reddy KR. Acute Liver Failure. Clinics in Liver Disease 2017;21:769-92. [DOI: 10.1016/j.cld.2017.06.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
82 Simmons OL, Meinzer C, Rule J, Lee WM; Acute Liver Failure Study Group. Liver Transplantation for Acetaminophen-Induced Acute Liver Failure: Role of Psychiatric Comorbidity in Listing Decisions and Outcomes. Dig Dis Sci 2020;65:1861-8. [PMID: 31679087 DOI: 10.1007/s10620-019-05901-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Steuerwald NM, Foureau DM, Norton HJ, Zhou J, Parsons JC, Chalasani N, Fontana RJ, Watkins PB, Lee WM, Reddy KR. Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance. PLoS One. 2013;e81974. [PMID: 24386086 DOI: 10.1371/journal.pone.0081974] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
84 Kwekel JC, Desai VG, Moland CL, Branham WS, Fuscoe JC. Age and sex dependent changes in liver gene expression during the life cycle of the rat. BMC Genomics 2010;11:675. [PMID: 21118493 DOI: 10.1186/1471-2164-11-675] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
85 Tsaroucha A, Chondrogiannis C, Mani A, Staikou C. Myocardial involvement during ischemia-induced acute liver failure in the pig. J Invest Surg 2013;26:99-104. [PMID: 23273174 DOI: 10.3109/08941939.2012.705953] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
86 Lee WM, Seremba E. Etiologies of acute liver failure. Curr Opin Crit Care 2008;14:198-201. [PMID: 18388683 DOI: 10.1097/MCC.0b013e3282f6a420] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
87 Loosen SH, Schueller F, Trautwein C, Roy S, Roderburg C. Role of circulating microRNAs in liver diseases. World J Hepatol 2017; 9(12): 586-594 [PMID: 28515844 DOI: 10.4254/wjh.v9.i12.586] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]
88 Urrunaga NH, Rachakonda VP, Magder LS, Mindikoglu AL. Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States. Transplant Proc. 2014;46:219-224. [PMID: 24507055 DOI: 10.1016/j.transproceed.2013.08.111] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
89 Lee WM, Polson J. Analyzing liver transplantation for fulminant hepatic failure at UCLA: A retrospective look at 18 years' experience. Liver Transpl 2004;10:953-5. [DOI: 10.1002/lt.20151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Stumpf JL, Skyles AJ, Alaniz C, Erickson SR. Knowledge of appropriate acetaminophen doses and potential toxicities in an adult clinic population. Journal of the American Pharmacists Association 2007;47:35-41. [DOI: 10.1331/1544-3191.47.1.35.stumpf] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
91 Kaur I, Singh J. Cholestatic hepatitis with intravenous ceftriaxone. Indian J Pharmacol 2011;43:474-5. [PMID: 21845011 DOI: 10.4103/0253-7613.83133] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
92 Thakare R, Alamoudi JA, Gautam N, Rodrigues AD, Alnouti Y. Species differences in bile acids II. Bile acid metabolism. J Appl Toxicol. 2018;38:1336-1352. [PMID: 29845631 DOI: 10.1002/jat.3645] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
93 Areia M, Romãozinho JM, Ferreira M, Amaro P, Leitão MC. Fulminant hepatic failure: a Portuguese experience. Eur J Gastroenterol Hepatol 2007;19:665-9. [PMID: 17625436 DOI: 10.1097/MEG.0b013e3281ac20da] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
94 Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, Davern TJ 2nd, Murray NG, McCashland T, Reisch JS, Robuck PR;  Acute Liver Failure Study Group. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137: 856-864, 864. e1. [PMID: 19524577 DOI: 10.1053/j.gastro.2009.06.006] [Cited by in Crossref: 402] [Cited by in F6Publishing: 288] [Article Influence: 33.5] [Reference Citation Analysis]
95 Ma Q, Lu AYH, Sibley DR. Pharmacogenetics, Pharmacogenomics, and Individualized Medicine. Pharmacol Rev 2011;63:437-59. [DOI: 10.1124/pr.110.003533] [Cited by in Crossref: 301] [Cited by in F6Publishing: 221] [Article Influence: 30.1] [Reference Citation Analysis]
96 Devarbhavi H, Patil M, Reddy VV, Singh R, Joseph T, Ganga D. Drug-induced acute liver failure in children and adults: Results of a single-centre study of 128 patients. Liver Int 2018;38:1322-9. [DOI: 10.1111/liv.13662] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
97 McIntyre RS, Panjwani ZD, Nguyen HT, Woldeyohannes HO, Alsuwaidan M, Soczynska JK, Lourenco MT, Konarski JZ, Kennedy SH. The hepatic safety profile of duloxetine: a review. Expert Opin Drug Metab Toxicol. 2008;4:281-285. [PMID: 18363543 DOI: 10.1517/17425255.4.3.281] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
98 Grama A, Burac L, Aldea CO, Bulata B, Delean D, Samasca G, Abrudan C, Sirbe C, Pop TL. Vitamin D-Binding Protein (Gc-Globulin) in Acute Liver Failure in Children. Diagnostics (Basel) 2020;10:E278. [PMID: 32375318 DOI: 10.3390/diagnostics10050278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
99 Meyer J, Balaphas A, Fontana P, Sadoul K, Morel P, Gonelle-gispert C, Bühler L. Platelets in liver regeneration. VOXS 2017;12:455-62. [DOI: 10.1111/voxs.12382] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
100 Hiramatsu A, Takahashi S, Aikata H, Azakami T, Katamura Y, Kawaoka T, Uka K, Yamashina K, Takaki S, Kodama H. Etiology and outcome of acute liver failure: retrospective analysis of 50 patients treated at a single center. J Gastroenterol Hepatol. 2008;23:1216-1222. [PMID: 18637059 DOI: 10.1111/j.1440-1746.2008.05402.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
101 Hatanaka T, Naganuma A, Tateyama Y, Yoshinari F, Hoshino T, Sato K, Hmwe SS, Aizaki H, Wakita T, Kakizaki S, Uraoka T. Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver Failure. Intern Med 2019;58:2969-75. [PMID: 31243225 DOI: 10.2169/internalmedicine.2982-19] [Reference Citation Analysis]
102 Fernandez TD, Mayorga C, Guéant JL, Blanca M, Cornejo-garcía JA. Contributions of pharmacogenetics and transcriptomics to the understanding of the hypersensitivity drug reactions. Allergy 2014;69:150-8. [DOI: 10.1111/all.12304] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
103 Devarbhavi H, Karanth D, Prasanna KS, Adarsh CK, Patil M. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents. Hepatology 2011;54:1344-50. [PMID: 21735470 DOI: 10.1002/hep.24527] [Cited by in Crossref: 52] [Cited by in F6Publishing: 36] [Article Influence: 5.2] [Reference Citation Analysis]
104 Lahdenpera A, Koivusalo A, Vakkuri A, Hockerstedt K, Isoniemi H. Value of albumin dialysis therapy in severe liver insufficiency. Transplant Int 2004;17:717-23. [DOI: 10.1111/j.1432-2277.2004.tb00500.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
105 Xia Q, Dai X, Huang J, Xu X, Yang Q, Liu X, Chen Y, Li L. A single-center experience of non-bioartificial liver support systems among Chinese patients with liver failure. Int J Artif Organs. 2014;37:442-454. [PMID: 25008954 DOI: 10.5301/ijao.5000341] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
106 Gregory B, Larson AM, Reisch J, Lee WM; Acute Liver Failure Study Group. Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure. J Investig Med 2010;58:707-10. [PMID: 20305573 DOI: 10.231/JIM.0b013e3181db8764] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
107 Dugan CM, Fullerton AM, Roth RA, Ganey PE. Natural killer cells mediate severe liver injury in a murine model of halothane hepatitis. Toxicol Sci 2011;120:507-18. [PMID: 21245496 DOI: 10.1093/toxsci/kfr005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
108 Vliegenthart AD, Antoine DJ, Dear JW. Target biomarker profile for the clinical management of paracetamol overdose. Br J Clin Pharmacol 2015;80:351-62. [PMID: 26076366 DOI: 10.1111/bcp.12699] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
109 Canbay A, Tacke F, Hadem J, Trautwein C, Gerken G, Manns MP. Acute liver failure: a life-threatening disease. Dtsch Arztebl Int 2011;108:714-20. [PMID: 22114640 DOI: 10.3238/arztebl.2011.0714] [Cited by in Crossref: 7] [Cited by in F6Publishing: 26] [Article Influence: 0.7] [Reference Citation Analysis]
110 Rangnekar AS, Ellerbe C, Durkalski V, McGuire B, Lee WM, Fontana RJ. Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients. Liver Transpl 2013;19:991-1000. [PMID: 23780824 DOI: 10.1002/lt.23688] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
111 Grewal J, Doan A, Hong AS, Amin A, Scapa JV, Hanna R, Durazo F, Yanny B. Drug-Induced Autoimmune Hepatitis From Hydralazine Leading to Acute Liver Failure and Liver Transplantation. ACG Case Rep J 2019;6:e00252. [PMID: 31832473 DOI: 10.14309/crj.0000000000000252] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Schmidt LE. Age and paracetamol self-poisoning. Gut 2005;54:686-90. [PMID: 15831917 DOI: 10.1136/gut.2004.054619] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
113 Zhang LQ, Nsumu M, Huang P, Heruth DP, Riordan SM, Shortt K, Zhang N, Grigoryev DN, Li DY, Friesen CA, Van Haandel L, Leeder JS, Olson J, Ye SQ. Novel Protective Role of Nicotinamide Phosphoribosyltransferase in Acetaminophen-Induced Acute Liver Injury in Mice. Am J Pathol 2018;188:1640-52. [PMID: 29684358 DOI: 10.1016/j.ajpath.2018.04.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
114 Lane AN, Higashi RM, Fan TW. Preclinical models for interrogating drug action in human cancers using Stable Isotope Resolved Metabolomics (SIRM). Metabolomics 2016;12:118. [PMID: 27489532 DOI: 10.1007/s11306-016-1065-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
115 Desanty KP, Amabile CM. Antidepressant-lnduced Liver Injury. Ann Pharmacother 2007;41:1201-11. [DOI: 10.1345/aph.1k114] [Cited by in Crossref: 50] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
116 Carrion AF, Martin P. Non-Intensive Care Unit Management of Acute Liver Failure. Clin Liver Dis 2018;22:389-401. [PMID: 29605073 DOI: 10.1016/j.cld.2018.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
117 Wang GQ, Deng YQ, Hou FQ. Overview of drug-induced liver injury in China. Clin Liver Dis (Hoboken) 2014;4:26-9. [PMID: 30992915 DOI: 10.1002/cld.386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
118 Stuart WD, Kulkarni RM, Gray JK, Vasiliauskas J, Leonis MA, Waltz SE. Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice. Hepatology. 2011;53:1618-1628. [PMID: 21520175 DOI: 10.1002/hep.24239] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
119 Holman NS, Mosedale M, Wolf KK, LeCluyse EL, Watkins PB. Subtoxic Alterations in Hepatocyte-Derived Exosomes: An Early Step in Drug-Induced Liver Injury? Toxicol Sci. 2016;151:365-375. [PMID: 26962055 DOI: 10.1093/toxsci/kfw047] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
120 Shaw PJ, Hopfensperger MJ, Ganey PE, Roth RA. Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. Toxicol Sci 2007;100:259-66. [PMID: 17709330 DOI: 10.1093/toxsci/kfm218] [Cited by in Crossref: 113] [Cited by in F6Publishing: 95] [Article Influence: 8.1] [Reference Citation Analysis]
121 Adhyapok P, Fu X, Sluka JP, Clendenon SG, Sluka VD, Wang Z, Dunn K, Klaunig JE, Glazier JA. A computational model of liver tissue damage and repair. PLoS One 2020;15:e0243451. [PMID: 33347443 DOI: 10.1371/journal.pone.0243451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Zhang Q, Guo X, Zhao S, Pang X, Wang Y, Zhang Y, Chi B. Prognostic performance of clinical indices and model scorings for acute-on-chronic liver failure: A study of 164 patients. Exp Ther Med 2016;11:1348-54. [PMID: 27073448 DOI: 10.3892/etm.2016.3037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
123 Al Mutairi F, Dwivedi G, Al Ameel T. Fulminant hepatic failure in association with quetiapine: a case report. J Med Case Rep. 2012;6:418. [PMID: 23234465 DOI: 10.1186/1752-1947-6-418] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
124 Ichai P, Laurent-Bellue A, Saliba F, Moreau D, Besch C, Francoz C, Valeyrie-Allanore L, Bretagne SR, Boudon M, Antonini TM, Artru F, Pittau G, Roux O, Azoulay D, Levesque E, Durand F, Guettier C, Samuel D. Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors. Transplantation. 2017;101:1830-1837. [PMID: 28207633 DOI: 10.1097/tp.0000000000001655] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 4.3] [Reference Citation Analysis]
125 Millonig G, Stadlmann S, Vogel W. Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur J Gastroenterol Hepatol. 2005;17:445-447. [PMID: 15756098 DOI: 10.1097/00042737-200504000-00009] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
126 Doyon S, Klein-schwartz W, Lee S, Beuhler MC. Fatalities involving acetaminophen combination products reported to United States poison centers. Clinical Toxicology 2013;51:941-8. [DOI: 10.3109/15563650.2013.848282] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
127 Hamdi T, Yessayan L, Yee J, Szamosfalvi B. High sodium continuous veno-venous hemodialysis with regional citrate anticoagulation and online dialysate generation in patients with acute liver failure and cerebral edema: High sodium CVVHD-RCA for cerebral edema. Hemodialysis International 2018;22:184-91. [DOI: 10.1111/hdi.12572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
128 Koch DG, Tillman H, Durkalski V, Lee WM, Reuben A. Development of a Model to Predict Transplant-free Survival of Patients With Acute Liver Failure. Clin Gastroenterol Hepatol. 2016;14:1199-1206.e2. [PMID: 27085756 DOI: 10.1016/j.cgh.2016.03.046] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
129 Reike-Kunze M, Zenouzi R, Hartel J, Krech T, Weidemann S, Sterneck M, Weiler-Normann C, Lohse AW, Schramm C, Sebode M. Drug-induced liver injury at a tertiary care centre in Germany: Model for end-stage liver disease is the best predictor of outcome. Liver Int 2021. [PMID: 34152686 DOI: 10.1111/liv.14985] [Reference Citation Analysis]
130 Bernal W, Hyyrylainen A, Gera A, Audimoolam VK, McPhail MJ, Auzinger G, Rela M, Heaton N, O'Grady JG, Wendon J, Williams R. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74-80. [PMID: 23439263 DOI: 10.1016/j.jhep.2013.02.010] [Cited by in Crossref: 235] [Cited by in F6Publishing: 190] [Article Influence: 29.4] [Reference Citation Analysis]
131 Simpson KJ, Bates CM, Henderson NC, Wigmore SJ, Garden OJ, Lee A, Pollok A, Masterton G, Hayes PC. The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl. 2009;15:600-609. [PMID: 19479803 DOI: 10.1002/lt.21681] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 6.3] [Reference Citation Analysis]
132 Beggs KM, Fullerton AM, Miyakawa K, Ganey PE, Roth RA. Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction. Toxicol Sci 2014;137:91-101. [PMID: 24097668 DOI: 10.1093/toxsci/kft226] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
133 Muhammad-Azam F, Nur-Fazila SH, Ain-Fatin R, Mustapha Noordin M, Yimer N. Histopathological changes of acetaminophen-induced liver injury and subsequent liver regeneration in BALB/C and ICR mice. Vet World 2019;12:1682-8. [PMID: 32009746 DOI: 10.14202/vetworld.2019.1682-1688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
134 Urrunaga NH, Magder LS, Weir MR, Rockey DC, Mindikoglu AL. Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List. Dig Dis Sci 2016;61:309-16. [PMID: 26386861 DOI: 10.1007/s10620-015-3870-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
135 Dara L, Liu Z, Kaplowitz N. Pathogenesis of Idiosyncratic Drug Induced Liver Injury. Liver Pathophysiology. Elsevier; 2017. pp. 87-100. [DOI: 10.1016/b978-0-12-804274-8.00005-9] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
136 Faraj W, Dar F, Bartlett A, Melendez HV, Marangoni G, Mukherji D, Vergani GM, Dhawan A, Heaton N, Rela M. Auxiliary liver transplantation for acute liver failure in children. Ann Surg. 2010;251:351-356. [PMID: 20054274 DOI: 10.1097/sla.0b013e3181bdfef6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 11] [Article Influence: 5.2] [Reference Citation Analysis]
137 Mort JR, Shiyanbola OO, Ndehi LN, Xu Y, Stacy JN. Opioid-Paracetamol Prescription Patterns and Liver Dysfunction: A Retrospective Cohort Study in a Population Served by a US Health Benefits Organization. Drug Safety 2011;34:1079-88. [DOI: 10.2165/11593100-000000000-00000] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
138 Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, Portmann BC, Heneghan MA. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology. 2009;50:538-545. [PMID: 19575457 DOI: 10.1002/hep.23042] [Cited by in Crossref: 105] [Cited by in F6Publishing: 86] [Article Influence: 8.8] [Reference Citation Analysis]
139 Gupta N, Patel C, Panda M. Hepatitis following famotidine: a case report. Cases J 2009;2:89. [PMID: 19173722 DOI: 10.1186/1757-1626-2-89] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
140 Whitehouse T, Wendon J. Acute liver failure. Best Pract Res Clin Gastroenterol. 2013;27:757-769. [PMID: 24160932 DOI: 10.1016/j.bpg.2013.08.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
141 Paschoal Junior FM, Nogueira RDC, Oliveira MDL, Paschoal EHA, Teixeira MJ, D’albuquerque LAC, Bor-seng-shu E. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure. Arq Neuro-Psiquiatr 2017;75:470-6. [DOI: 10.1590/0004-282x20170076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
142 Bosoi CR, Rose CF. Brain edema in acute liver failure and chronic liver disease: similarities and differences. Neurochem Int 2013;62:446-57. [PMID: 23376027 DOI: 10.1016/j.neuint.2013.01.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
143 García-Cortés M, Ortega-Alonso A, Lucena MI, Andrade RJ; Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos GEHAM).l. Drug-induced liver injury: a safety review. Expert Opin Drug Saf 2018;17:795-804. [PMID: 30059261 DOI: 10.1080/14740338.2018.1505861] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
144 Nathwani RA, Kaplowitz N. Drug hepatotoxicity. Clin Liver Dis 2006;10:207-17, vii. [PMID: 16971258 DOI: 10.1016/j.cld.2006.05.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
145 Fontana RJ. Approaches to the Study of Drug-Induced Liver Injury. Clin Pharmacol Ther 2010;88:416-9. [DOI: 10.1038/clpt.2010.100] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
146 Andrade RJ, López-Ortega S, López-Vega MC, Robles M, Cueto I, Lucena MI. Idiosyncratic drug hepatotoxicity: a 2008 update. Expert Rev Clin Pharmacol 2008;1:261-76. [PMID: 24422651 DOI: 10.1586/17512433.1.2.261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
147 John K, Hadem J, Krech T, Wahl K, Manns MP, Dooley S, Batkai S, Thum T, Schulze-Osthoff K, Bantel H. MicroRNAs play a role in spontaneous recovery from acute liver failure. Hepatology. 2014;60:1346-1355. [PMID: 24913549 DOI: 10.1002/hep.27250] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 8.4] [Reference Citation Analysis]
148 Kozer E, Greenberg R, Zimmerman D, Berkovitch M. Repeated supratherapeutic doses of paracetamol in children—a literature review and suggested clinical approach. Acta Paediatrica 2006;95:1165-71. [DOI: 10.1080/08035250600580503] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
149 Thurin NH, Lassalle R, Schuemie M, Pénichon M, Gagne JJ, Rassen JA, Benichou J, Weill A, Blin P, Moore N, Droz-Perroteau C. Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS). Pharmacoepidemiol Drug Saf 2021;30:320-33. [PMID: 33099844 DOI: 10.1002/pds.5161] [Reference Citation Analysis]
150 Hedrington MS, Davis SN. Peroxisome proliferator-activated receptor alpha-mediated drug toxicity in the liver. Expert Opin Drug Metab Toxicol 2018;14:671-7. [PMID: 29847748 DOI: 10.1080/17425255.2018.1483337] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
151 Guler N, Unalp O, Guler A, Yaprak O, Dayangac M, Sozbilen M, Akyildiz M, Tokat Y. Glasgow coma scale and APACHE-II scores affect the liver transplantation outcomes in patients with acute liver failure. Hepatobiliary & Pancreatic Diseases International 2013;12:589-93. [DOI: 10.1016/s1499-3872(13)60093-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
152 陈欣黎, 孟强, 刘克辛. STAT3信号通路在肝损伤保护中的作用. 世界华人消化杂志 2014; 22(8): 1051-1057 [DOI: 10.11569/wcjd.v22.i8.1051] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
153 Shen JX, Youhanna S, Zandi Shafagh R, Kele J, Lauschke VM. Organotypic and Microphysiological Models of Liver, Gut, and Kidney for Studies of Drug Metabolism, Pharmacokinetics, and Toxicity. Chem Res Toxicol 2020;33:38-60. [DOI: 10.1021/acs.chemrestox.9b00245] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
154 Lo C. Liver transplantation for acute liver failure: Not too early but never too late. Liver Transpl 2008;14:1243-4. [DOI: 10.1002/lt.21536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
155 Coté GA, Gottstein JH, Daud A, Blei AT; Acute Liver Failure Study Group. The role of etiology in the hyperamylasemia of acute liver failure. Am J Gastroenterol 2009;104:592-7. [PMID: 19223884 DOI: 10.1038/ajg.2008.84] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
156 Kancherla D, Gajendran M, Vallabhaneni P, Vipperla K. Metronidazole induced liver injury: a rare immune mediated drug reaction. Case Rep Gastrointest Med 2013;2013:568193. [PMID: 24455335 DOI: 10.1155/2013/568193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
157 Mihm S. Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver. Int J Mol Sci 2018;19:E3104. [PMID: 30309020 DOI: 10.3390/ijms19103104] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 17.0] [Reference Citation Analysis]
158 Mcelreath DP, Angtuaco TL, Staggs B, Malik AH. T Cell Prolymphocytic Leukemia: A Rare Cause of Acute Liver Failure. Dig Dis Sci 2006;51:819-21. [DOI: 10.1007/s10620-006-3213-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
159 Canbay A, Tacke F, Hadem J, Trautwein C, Gerken G, Manns MP. Acute liver failure: a life-threatening disease. Dtsch Arztebl Int. 2011;108:714-720. [PMID: 22114640 DOI: 10.3238/arztebl.2011.0714.Epub] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
160 Guindi M. Wilson disease. Semin Diagn Pathol. 2019;36:415-422. [PMID: 31421978 DOI: 10.1053/j.semdp.2019.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
161 Chen L, Wang P, Manautou JE, Zhong XB. Knockdown of Long Noncoding RNAs Hepatocyte Nuclear Factor 1α Antisense RNA 1 and Hepatocyte Nuclear Factor 4α Antisense RNA 1 Alters Susceptibility of Acetaminophen-Induced Cytotoxicity in HepaRG Cells. Mol Pharmacol 2020;97:278-86. [PMID: 32029527 DOI: 10.1124/mol.119.118778] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
162 Miyake Y, Iwasaki Y, Makino Y, Kobashi H, Takaguchi K, Ando M, Sakaguchi K, Shiratori Y. Prognostic factors for fatal outcomes prior to receiving liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure. J Gastroenterol Hepatol 2007;22:855-61. [PMID: 17565642 DOI: 10.1111/j.1440-1746.2007.04874.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
163 Steadman RH, Van Rensburg A, Kramer DJ. Transplantation for acute liver failure: perioperative management: . Current Opinion in Organ Transplantation 2010;15:368-73. [DOI: 10.1097/mot.0b013e32833982dd] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
164 Lee B, Park J, Ha TKQ, Pham HTT, An J, Noh J, Lee C, Oh W. Constituents of the Edible Leaves of Melicope pteleifolia with Potential Analgesic Activity. J Nat Prod 2019;82:2201-10. [DOI: 10.1021/acs.jnatprod.9b00224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
165 Chayanupatkul M, Schiano TD. Acute Liver Failure Secondary to Drug-Induced Liver Injury. Clin Liver Dis 2020;24:75-87. [PMID: 31753252 DOI: 10.1016/j.cld.2019.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
166 Deterding K, Tegtmeyer B, Cornberg M, Hadem J, Potthoff A, Böker KH, Tillmann HL, Manns MP, Wedemeyer H. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV. J Hepatol. 2006;45:770-778. [PMID: 17034895 DOI: 10.1016/j.jhep.2006.07.023] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
167 Goldring C, Antoine DJ, Bonner F, Crozier J, Denning C, Fontana RJ, Hanley NA, Hay DC, Ingelman-Sundberg M, Juhila S, Kitteringham N, Silva-Lima B, Norris A, Pridgeon C, Ross JA, Young RS, Tagle D, Tornesi B, van de Water B, Weaver RJ, Zhang F, Park BK. Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury. Hepatology 2017;65:710-21. [PMID: 27775817 DOI: 10.1002/hep.28886] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
168 Dong V, Nanchal R, Karvellas CJ. Pathophysiology of Acute Liver Failure. Nutr Clin Pract. 2020;35:24-29. [PMID: 31840297 DOI: 10.1002/ncp.10459] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
169 Shehu AI, Ma X, Venkataramanan R. Mechanisms of Drug-Induced Hepatotoxicity. Clin Liver Dis. 2017;21:35-54. [PMID: 27842774 DOI: 10.1016/j.cld.2016.08.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
170 Kramer DJ. Invited commentary: septic shock in acute liver failure. J Crit Care 2008;23:473-4. [PMID: 19056009 DOI: 10.1016/j.jcrc.2008.08.014] [Reference Citation Analysis]
171 Toyoda Y, Miyashita T, Endo S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Estradiol and progesterone modulate halothane-induced liver injury in mice. Toxicology Letters 2011;204:17-24. [DOI: 10.1016/j.toxlet.2011.03.031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
172 Rodrigues-Filho EM, Fernandes R, Garcez A. SOFA in the first 24 hours as an outcome predictor of acute liver failure. Rev Bras Ter Intensiva. 2018;30:64-70. [PMID: 29742228 DOI: 10.5935/0103-507x.20180012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
173 Lea JD, Clarke JI, McGuire N, Antoine DJ. Redox-Dependent HMGB1 Isoforms as Pivotal Co-Ordinators of Drug-Induced Liver Injury: Mechanistic Biomarkers and Therapeutic Targets. Antioxid Redox Signal 2016;24:652-65. [PMID: 26481429 DOI: 10.1089/ars.2015.6406] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
174 Obogwu MB, Akindele AJ, Adeyemi OO. Hepatoprotective and in vivo antioxidant activities of the hydroethanolic leaf extract of Mucuna pruriens (Fabaceae) in antitubercular drugs and alcohol models. Chin J Nat Med 2014;12:273-83. [PMID: 24863352 DOI: 10.1016/S1875-5364(14)60054-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
175 Karimi K, Keßler T, Thiele K, Ramisch K, Erhardt A, Huebener P, Barikbin R, Arck P, Tiegs G. Prenatal acetaminophen induces liver toxicity in dams, reduces fetal liver stem cells, and increases airway inflammation in adult offspring. J Hepatol 2015;62:1085-91. [PMID: 25529619 DOI: 10.1016/j.jhep.2014.12.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
176 Kapuria D, Strasser K, Qasem A. Diffuse large B-cell lymphoma causing acute liver failure: a rare case of survival. BMJ Case Rep 2015;2015:bcr2015209328. [PMID: 25969490 DOI: 10.1136/bcr-2015-209328] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
177 Broglio K, Pergolizzi J, Kowalski M, Lynch SY, He E, Wen W. Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic Pain. Pain Pract 2017;17:382-91. [PMID: 27317188 DOI: 10.1111/papr.12462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
178 Devarbhavi H, Joseph T, Sunil Kumar N, Rathi C, Thomas V, Prasad Singh S, Sawant P, Goel A, Eapen CE, Rai P, Arora A, Leelakrishnan V, Gopalakrishnan G, Vardhan Reddy V, Singh R, Goswami B, Venkataraman J, Balaraju G, Patil M, Patel R, Taneja S, Koshy A, Nagaraja Rao P, Kumar Sarin S, Rathi P, Dhiman R, Duseja AK, Vargese J, Kumar Jain A, Wadhawan M, Ranjan P, Karanth D, Ganesh P, Nijhawan S, Krishna Dhali G, Adarsh CK, Jhaveri A, Nagral A, Rao P, Shalimar. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients. J Clin Exp Hepatol 2021;11:288-98. [PMID: 33994711 DOI: 10.1016/j.jceh.2020.11.002] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
179 Castaldo ET, Chari RS. Liver transplantation for acute hepatic failure. HPB (Oxford) 2006;8:29-34. [PMID: 18333235 DOI: 10.1080/13651820500465741] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
180 Khalid SK, Lane J, Navarro V, Garcia-Tsao G. Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis. Clin Gastroenterol Hepatol 2009;7:994-9; quiz 913-4. [PMID: 19394441 DOI: 10.1016/j.cgh.2009.04.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
181 Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ. ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. American Journal of Gastroenterology 2014;109:950-66. [DOI: 10.1038/ajg.2014.131] [Cited by in Crossref: 408] [Cited by in F6Publishing: 339] [Article Influence: 58.3] [Reference Citation Analysis]
182 Andrade RJ, Robles M, Fernández-Castañer A, López-Ortega S, López-Vega MC, Lucena MI. Assessment of drug-induced hepatotoxicity in clinical practice: A challenge for gastroenterologists. World J Gastroenterol 2007; 13(3): 329-340 [PMID: 17230599 DOI: 10.3748/wjg.v13.i3.329] [Cited by in CrossRef: 87] [Cited by in F6Publishing: 66] [Article Influence: 6.2] [Reference Citation Analysis]
183 Rovegno M, Vera M, Ruiz A, Benítez C. Current concepts in acute liver failure. Ann Hepatol 2019;18:543-52. [PMID: 31126880 DOI: 10.1016/j.aohep.2019.04.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
184 Metushi IG, Sanders C, Lee WM, Uetrecht J; Acute Liver Study Group. Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure. Hepatology 2014;59:1084-93. [PMID: 23775837 DOI: 10.1002/hep.26564] [Cited by in Crossref: 81] [Cited by in F6Publishing: 69] [Article Influence: 11.6] [Reference Citation Analysis]
185 Mckenzie M, Johnson JL, Anderson K, Summers R, Wood P. Exploring Australian pharmacists' perceptions and attitudes toward codeine up-scheduling from over-the-counter to prescription only. Pharm Pract (Granada) 2020;18:1904. [PMID: 32566049 DOI: 10.18549/PharmPract.2020.2.1904] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Ebrahimi M, Mousavi SR, Toussi AG, Reihani H, Bagherian F. Comparing the Therapeutic Effectiveness of N-acetylcysteine with the Combination of N-acetyl Cysteine and Cimetidine in Acute Acetaminophen Toxicity: A Double-Blinded Clinical Trial. Electron Physician 2015;7:1310-7. [PMID: 26516435 DOI: 10.14661/1310] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
187 Lauschke VM. Toxicogenomics of drug induced liver injury - from mechanistic understanding to early prediction. Drug Metab Rev 2021;53:245-52. [PMID: 33683927 DOI: 10.1080/03602532.2021.1894571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
188 Kasper H, Drebber U, Hirsch I, Dienes HP. Morphologische Veränderungen der medikamenteninduzierten Leberschädigung. Pathologe 2006;27:175-81. [DOI: 10.1007/s00292-006-0826-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
189 Kantola T, Ilmakunnas M, Koivusalo A, Isoniemi H. Bridging Therapies and Liver Transplantation in Acute Liver Failure; 10 Years of MARS Experience from Finland. Scand J Surg 2011;100:8-13. [DOI: 10.1177/145749691110000103] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
190 He Y, Xia Z, Yu D, Wang J, Jin L, Huang D, Ye X, Li X, Zhang B. Hepatoprotective effects and structure-activity relationship of five flavonoids against lipopolysaccharide/d-galactosamine induced acute liver failure in mice. Int Immunopharmacol 2019;68:171-8. [PMID: 30641432 DOI: 10.1016/j.intimp.2018.12.059] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
191 Tran T, Lee WM. DILI: New Insights into Diagnosis and Management. Curr Hepat Rep 2013;12:53-8. [PMID: 23730228 DOI: 10.1007/s11901-012-0159-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
192 Lim Y. Acute liver failure in Korea: etiology, prognosis and treatment. Korean J Hepatol 2010;16:5. [DOI: 10.3350/kjhep.2010.16.1.5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
193 Xue F, Strombom I, Turnbull B, Zhu S, Seeger JD. Duloxetine for depression and the incidence of hepatic events in adults. J Clin Psychopharmacol. 2011;31:517-522. [PMID: 21694615 DOI: 10.1097/jcp.0b013e31822347d9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
194 Fan WL, Shiao MS, Hui RC, Su SC, Wang CW, Chang YC, Chung WH. HLA Association with Drug-Induced Adverse Reactions. J Immunol Res 2017;2017:3186328. [PMID: 29333460 DOI: 10.1155/2017/3186328] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
195 Fontana RJ, Stravitz RT, Durkalski V, Hanje J, Hameed B, Koch D, Ganger D, Olson J, Liou I, McGuire BM, Clasen K, Lee WM. Prognostic Value of the 13 C-Methacetin Breath Test in Adults with Acute Liver Failure and Non-acetaminophen Acute Liver Injury. Hepatology 2021;74:961-72. [PMID: 33660316 DOI: 10.1002/hep.31783] [Reference Citation Analysis]
196 Fontana RJ. Should aciclovir be given to all patients presenting with acute liver failure of unknown etiology? Nat Clin Pract Gastroenterol Hepatol 2008;5:298-9. [PMID: 18477988 DOI: 10.1038/ncpgasthep1128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
197 Renner EL. How to decide when to list a patient with acute liver failure for liver transplantation? Clichy or King’s College criteria, or something else? Journal of Hepatology 2007;46:554-7. [DOI: 10.1016/j.jhep.2007.01.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
198 Au SH, Chamberlain MD, Mahesh S, Sefton MV, Wheeler AR. Hepatic organoids for microfluidic drug screening. Lab Chip. 2014;14:3290-3299. [PMID: 24984750 DOI: 10.1039/c4lc00531g] [Cited by in Crossref: 93] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
199 Ganger DR, Rule J, Rakela J, Bass N, Reuben A, Stravitz RT, Sussman N, Larson AM, James L, Chiu C, Lee WM; Acute Liver Failure Study Group. Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality. Am J Gastroenterol 2018;113:1319. [PMID: 29946176 DOI: 10.1038/s41395-018-0160-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
200 Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008;14 Suppl 2:S67-S79. [PMID: 18825677 DOI: 10.1002/lt.21612] [Cited by in Crossref: 126] [Cited by in F6Publishing: 95] [Article Influence: 10.5] [Reference Citation Analysis]
201 Kim AI, Han S, Tran D, Sullivan P, Lassman C, Raman S, Zimmerman P, Chin EE. Abdominal imaging can misdiagnose submassive hepatic necrosis as cirrhosis in acute liver failure. Clin Transplant 2013;27:E339-45. [DOI: 10.1111/ctr.12123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
202 Njoku DB. Drug-induced hepatotoxicity: metabolic, genetic and immunological basis. Int J Mol Sci. 2014;15:6990-7003. [PMID: 24758937 DOI: 10.3390/ijms15046990] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
203 Hebels DG, Jetten MJ, Aerts HJ, Herwig R, Theunissen DH, Gaj S, van Delft JH, Kleinjans JC. Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicity. Biomarkers in Medicine 2014;8:185-200. [DOI: 10.2217/bmm.13.154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
204 Costiniuk CT, Gosnell BI, Manzini TC, Du Plessis CN, Moosa MY. Tuberculous Drug-induced Liver Injury and Treatment Re-challenge in Human Immunodeficiency Virus Co-infection. J Glob Infect Dis. 2015;7:151-156. [PMID: 26752869 DOI: 10.4103/0974-777X.170499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
205 Dumortier C, Djossou F, Bernuau J, Basurko C, Blanchon T, Flahault A, Leport C. Factors Associated With Increased Serum Alanine Aminotransferase Levels During the French Guiana Dengue Epidemic of 2005-2006. Infectious Diseases in Clinical Practice 2010;18:41-5. [DOI: 10.1097/ipc.0b013e3181c75415] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
206 Charnot-Katsikas A, Baewer D, Cook L, David MZ. Fulminant hepatic failure attributed to infection with human herpesvirus 6 (HHV-6) in an immunocompetent woman: A case report and review of the literature. J Clin Virol 2016;75:27-32. [PMID: 26745830 DOI: 10.1016/j.jcv.2015.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
207 . 36th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 24-27 May, 2016, Madrid, Spain. Clinical Toxicology 2016;54:344-519. [DOI: 10.3109/15563650.2016.1165952] [Cited by in Crossref: 49] [Cited by in F6Publishing: 6] [Article Influence: 9.8] [Reference Citation Analysis]
208 Alonso EM, Horslen SP, Behrens EM, Doo E. Pediatric acute liver failure of undetermined cause: A research workshop. Hepatology. 2017;65:1026-1037. [PMID: 27862115 DOI: 10.1002/hep.28944] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
209 Porteous J, Cioccari L, Ancona P, Osawa E, Jones K, Gow P, Angus P, Warrillow S, Bellomo R. Outcome of Acetaminophen‐Induced Acute Liver Failure Managed Without Intracranial Pressure Monitoring or Transplantation. Liver Transpl 2019;25:35-44. [DOI: 10.1002/lt.25377] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
210 Ng VL, Li R, Loomes KM, Leonis MA, Rudnick DA, Belle SH, Squires RH; Pediatric Acute Liver Failure Study Group (PALFSG). Outcomes of Children With and Without Hepatic Encephalopathy From the Pediatric Acute Liver Failure Study Group. J Pediatr Gastroenterol Nutr 2016;63:357-64. [PMID: 27367788 DOI: 10.1097/MPG.0000000000001178] [Cited by in Crossref: 32] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
211 Davis ML, Hashemi N. Acute liver failure as a rare initial manifestation of peripheral T-cell lymphoma. World J Hepatol 2010; 2(10): 384-386 [PMID: 21160947 DOI: 10.4254/wjh.v2.i10.384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
212 McCormick PA, Treanor D, McCormack G, Farrell M. Early death from paracetamol (acetaminophen) induced fulminant hepatic failure without cerebral oedema. J Hepatol. 2003;39:547-551. [PMID: 12971964 DOI: 10.1016/s0168-8278(03)00299-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
213 Jalan R, Williams R, Bernuau J. Paracetamol: are therapeutic doses entirely safe? The Lancet 2006;368:2195-6. [DOI: 10.1016/s0140-6736(06)69874-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
214 Bhattacharya S, Shoda LK, Zhang Q, Woods CG, Howell BA, Siler SQ, Woodhead JL, Yang Y, McMullen P, Watkins PB, Andersen ME. Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches. Front Physiol 2012;3:462. [PMID: 23248599 DOI: 10.3389/fphys.2012.00462] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
215 Siniscalchi A, Dante A, Spedicato S, Riganello L, Zanoni A, Cimatti M, Pierucci E, Bernardi E, Miklosova Z, Moretti C. Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. Transplant Proc. 2010;42:1197-1199. [PMID: 20534260 DOI: 10.1016/j.transproceed.2010.03.097] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
216 Liu W, Makrauer FL, Qamar AA, Jänne PA, Odze RD. Fulminant Hepatic Failure Secondary to Erlotinib. Clinical Gastroenterology and Hepatology 2007;5:917-20. [DOI: 10.1016/j.cgh.2007.04.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
217 Mendrick DL, Daniels KK. Biomarkers of drug-induced adverse events. Expert Review of Clinical Pharmacology 2014;1:81-91. [DOI: 10.1586/17512433.1.1.81] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
218 Ajmera V, Xia G, Vaughan G, Forbi JC, Ganova-Raeva LM, Khudyakov Y, Opio CK, Taylor R, Restrepo R, Munoz S, Fontana RJ, Lee WM;  Acute Liver Failure Study Group. What factors determine the severity of hepatitis A-related acute liver failure? J Viral Hepat. 2011;18:e167-e174. [PMID: 21143345 DOI: 10.1111/j.1365-2893.2010.01410.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
219 Fujiwara K, Yasui S, Yokosuka O. Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure. Hepatol Int 2013;7:335-46. [DOI: 10.1007/s12072-012-9402-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
220 Grieco A, Miele L, Forgione A, Ragazzoni E, Vecchio FM, Gasbarrini G. Mild hepatitis at recommended doses of acetaminophen in patients with evidence of constitutionally enhanced cytochrome P450 system activity. J Clin Pharm Ther 2008;33:315-20. [PMID: 18452419 DOI: 10.1111/j.1365-2710.2008.00918.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
221 Rabaglio M, Ruepp B; (For the Soft/Text/Perche Steering Committee). Death due to liver failure during endocrine therapy for premenopausal breast cancer. Acta Oncologica 2010;49:874-6. [DOI: 10.3109/0284186x.2010.484813] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
222 Kim H, Kim Y, Guk K, Yoo D, Lim H, Kang G, Lee D. Fully biodegradable and cationic poly(amino oxalate) particles for the treatment of acetaminophen-induced acute liver failure. Int J Pharm 2012;434:243-50. [PMID: 22664461 DOI: 10.1016/j.ijpharm.2012.05.067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
223 Voigt MD. Predicting death in patients with acetaminophen-induced acute liver failure: The King's college hospital model is on the SOFA, not the mat. Liver Transpl 2012;18:384-6. [DOI: 10.1002/lt.23386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
224 Shah I, Putnam T, Daugherty E, Vyas N, Chuang KY. Mifepristone: An Uncommon Cause of Drug-Induced Liver Injury. Gastroenterology Res 2019;12:181-4. [PMID: 31236162 DOI: 10.14740/gr1188] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
225 Ling G, Pinsk V, Golan-Tripto I, Ling E. Acute Liver Failure in a Pediatric Patient with Congenital Dysery-Thropoietic Anemia Type I Treated with Deferasirox. Hematol Rep 2015;7:5987. [PMID: 26487935 DOI: 10.4081/hr.2015.5987] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
226 Palmes D, Skawran S, Stratmann U, Armann B, Minin E, Herbst H, Spiegel HU. Amelioration of microcirculatory damage by an endothelin A receptor antagonist in a rat model of reversible acute liver failure. J Hepatol. 2005;42:350-357. [PMID: 15710217 DOI: 10.1016/j.jhep.2004.11.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
227 Mrzljak A, Kosuta I, Skrtic A, Kanizaj TF, Vrhovac R. Drug-Induced Liver Injury Associated with Noni (Morinda citrifolia) Juice and Phenobarbital. Case Rep Gastroenterol. 2013;7:19-24. [PMID: 23467452 DOI: 10.1159/000343651] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
228 Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, Saab S, Wisniewski KA, Trotter JF; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2008;14:1273-80. [PMID: 18756453 DOI: 10.1002/lt.21500] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 5.9] [Reference Citation Analysis]
229 Yu Y, Nie X, Song Z, Xie Y, Zhang X, Du Z, Wei R, Fan D, Liu Y, Zhao Q, Peng X, Jia L, Wang X. Signal Detection of Potentially Drug-Induced Liver Injury in Children Using Electronic Health Records. Front Pediatr 2020;8:171. [PMID: 32373564 DOI: 10.3389/fped.2020.00171] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Güngör Ş, Selimoğlu MA, Bağ HGG, Varol FI. Is it possible to diagnose fulminant Wilson's disease with simple laboratory tests? Liver Int 2020;40:155-62. [PMID: 31568639 DOI: 10.1111/liv.14263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
231 Giri S, Nieber K, Bader A. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages. Expert Opinion on Drug Metabolism & Toxicology 2010;6:895-917. [DOI: 10.1517/17425251003792521] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
232 Daly AK. Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury? Pharm Res 2017;34:1564-9. [PMID: 28028769 DOI: 10.1007/s11095-016-2091-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
233 Maiuri AR, Wassink B, Turkus JD, Breier AB, Lansdell T, Kaur G, Hession SL, Ganey PE, Roth RA. Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study. J Pharmacol Exp Ther 2017;362:459-73. [PMID: 28687704 DOI: 10.1124/jpet.117.242354] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
234 Mielnicki W, Dyla A, Karczewski M. Clinical effectiveness of MARS treatment - multidirectional analysis of positive clinical response to treatment. Clin Exp Hepatol 2019;5:271-8. [PMID: 31893237 DOI: 10.5114/ceh.2019.89163] [Reference Citation Analysis]
235 Mohammed SAA, Khan RA, El-Readi MZ, Emwas AH, Sioud S, Poulson BG, Jaremko M, Eldeeb HM, Al-Omar MS, Mohammed HA. Suaeda vermiculata Aqueous-Ethanolic Extract-Based Mitigation of CCl4-Induced Hepatotoxicity in Rats, and HepG-2 and HepG-2/ADR Cell-Lines-Based Cytotoxicity Evaluations. Plants (Basel) 2020;9:E1291. [PMID: 33003604 DOI: 10.3390/plants9101291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
236 Lucyk SN, Yarema MC, Sivilotti ML, Johnson DW, Nettel-Aguirre A, Victorino C, Bailey B, Dart RC, Heard K, Spyker DA, Rumack BH. Outcomes of Patients With Premature Discontinuation of the 21-h Intravenous N-Acetylcysteine Protocol After Acute Acetaminophen Overdose. J Emerg Med 2016;50:629-37. [PMID: 26899513 DOI: 10.1016/j.jemermed.2015.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
237 Long RC, Wofford MR, Harkins KG, Minor DS. Hepatocellular Necrosis Associated With Labetalol. The Journal of Clinical Hypertension 2007;9:287-90. [DOI: 10.1111/j.1524-6175.2007.06351.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
238 Kosmidou IS, Aggarwal A, Ross JJ, Worthington MG. Hodgkin’ s disease with fulminant non-alcoholic steatohepatitis. Dig Liver Dis. 2004;36:691-693. [PMID: 15506670 DOI: 10.1016/j.dld.2003.12.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
239 Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004;10:1018-1023. [PMID: 15390328 DOI: 10.1002/lt.20204] [Cited by in Crossref: 311] [Cited by in F6Publishing: 269] [Article Influence: 18.3] [Reference Citation Analysis]
240 Vanga RR, Bal B, Olden KW. Adderall induced acute liver injury: a rare case and review of the literature. Case Rep Gastrointest Med 2013;2013:902892. [PMID: 23864967 DOI: 10.1155/2013/902892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
241 Weiss S. Compliance packaging for over-the-counter drug products. J Public Health 2009;17. [DOI: 10.1007/s10389-008-0233-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
242 Cheng L, You Q, Yin H, Holt M, Franklin C, Ju C. Effect of polyI:C cotreatment on halothane-induced liver injury in mice. Hepatology 2009;49:215-26. [PMID: 19111017 DOI: 10.1002/hep.22585] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
243 Rakela J, Rule J, Ganger D, Lau J, Cunningham J, Dehankar M, Baheti S, Lee WM; Acute Liver Failure Study Group. Whole Exome Sequencing Among 26 Patients With Indeterminate Acute Liver Failure: A Pilot Study. Clin Transl Gastroenterol 2019;10:e00087. [PMID: 31609742 DOI: 10.14309/ctg.0000000000000087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
244 Alhaddad O, Elsabaawy M, Abdelsameea E, Abdallah A, Shabaan A, Ehsan N, Elrefaey A, Elsabaawy D, Salama M. Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt. Sci Rep 2020;10:5124. [PMID: 32198411 DOI: 10.1038/s41598-020-61872-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
245 Yang F, Takeuchi T, Tsuneyama K, Yokoi T, Oda S. Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats. Toxicol Sci 2019;170:95-108. [PMID: 30985903 DOI: 10.1093/toxsci/kfz088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
246 Huang C, Zheng J, Ma D, Liu N, Zhu C, Li J, Yang R. Hypoxia-triggered gene therapy: a new drug delivery system to utilize photodynamic-induced hypoxia for synergistic cancer therapy. J Mater Chem B 2018;6:6424-30. [DOI: 10.1039/c8tb01805g] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 6.3] [Reference Citation Analysis]
247 Wu DB, Chen EQ, Bai L, Tang H. Propylthiouracil-induced liver failure and artificial liver support systems: a case report and review of the literature. Ther Clin Risk Manag 2017;13:65-8. [PMID: 28138249 DOI: 10.2147/TCRM.S122611] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
248 Njoku DB, Mellerson JL, Talor MV, Kerr DR, Faraday NR, Outschoorn I, Rose NR. Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis. Clin Vaccine Immunol. 2006;13:258-265. [PMID: 16467335 DOI: 10.1128/cvi.13.2.258-265.2006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
249 Ulcickas Yood M, Bortolini M, Casso D, Beck JG, Oliveria SA, Wells KE, Woodcroft KJ, Wang LI. Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system. Pharmacoepidemiol Drug Saf. 2015;24:427-434. [PMID: 25683797 DOI: 10.1002/pds.3757] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
250 Dallak M, Dawood AF, Haidara MA, Abdel Kader DH, Eid RA, Kamar SS, Shams Eldeen AM, Al-Ani B. Suppression of glomerular damage and apoptosis and biomarkers of acute kidney injury induced by acetaminophen toxicity using a combination of resveratrol and quercetin. Drug Chem Toxicol 2020;:1-7. [PMID: 32013615 DOI: 10.1080/01480545.2020.1722156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
251 Camus C, Lavoué S, Gacouin A, Le Tulzo Y, Lorho R, Boudjéma K, Jacquelinet C, Thomas R. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med 2006;32:1817-25. [PMID: 16941171 DOI: 10.1007/s00134-006-0340-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
252 Germani G, Battistella S, Ulinici D, Zanetto A, Shalaby S, Pellone M, Gambato M, Senzolo M, Russo FP, Burra P. Drug induced liver injury: from pathogenesis to liver transplantation. Minerva Gastroenterol 2021;67. [DOI: 10.23736/s2724-5985.20.02795-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Rubin JB, Hameed B, Gottfried M, Lee WM, Sarkar M; Acute Liver Failure Study Group. Acetaminophen-induced Acute Liver Failure Is More Common and More Severe in Women. Clin Gastroenterol Hepatol 2018;16:936-46. [PMID: 29199145 DOI: 10.1016/j.cgh.2017.11.042] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
254 Seife Hassen S, Ata F, Bint I Bilal A, Salih Ali M, Petkar M, Awad Elzouki AY, Zahid M. Immune-mediated drug-induced liver injury secondary to Omeprazole: A case report. Clin Case Rep 2020;8:3421-6. [PMID: 33363945 DOI: 10.1002/ccr3.3421] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
255 Li P, Li S, Gu H, Lu Q, Jiang W, Pei X, Sun Y, Xu H, Wang G, Hao K. The exposure-effect-toxicity correlation of docetaxel and magnesium isoglycyrrhizinate in non-small cell lung tumor-bearing mice. Biomedicine & Pharmacotherapy 2018;97:1000-10. [DOI: 10.1016/j.biopha.2017.10.158] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
256 Mendez-sanchez N, Chavez-tapia NC, Espinoza B, Herrera-gomar M, Zamora-valdes D, Uribe M. Acute liver failure and the molecular adsorbents recirculating system: Early experience in a tertiary care hospital in Mexico City. Annals of Hepatology 2004;3:164-6. [DOI: 10.1016/s1665-2681(19)32096-4] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
257 Lee SJ, Lee YJ, Park KK. The pathogenesis of drug-induced liver injury. Expert Rev Gastroenterol Hepatol 2016;10:1175-85. [PMID: 27248313 DOI: 10.1080/17474124.2016.1196133] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
258 Basta G, Del Turco S, Navarra T, Lee WM; Acute Liver Failure Study Group. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure. Liver Transpl 2015;21:847-54. [PMID: 25825217 DOI: 10.1002/lt.24129] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
259 Hinson JA, Roberts DW, James LP. Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol. 2010;369-405. [PMID: 20020268 DOI: 10.1007/978-3-642-00663-0_12] [Cited by in Crossref: 498] [Cited by in F6Publishing: 457] [Article Influence: 45.3] [Reference Citation Analysis]
260 Singhal S, Kohaar I, Bharadwaj M, Shukla DK, Das BC, Kar P. Association of Tumor Necrosis Factor-Alpha Gene Promoter Polymorphisms with Acute Viral Hepatitis in the Indian Population. Dig Dis Sci 2010;55:1106-12. [DOI: 10.1007/s10620-009-0799-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
261 Joshi GP. Valdecoxib for the management of chronic and acute pain. Expert Review of Neurotherapeutics 2014;5:11-24. [DOI: 10.1586/14737175.5.1.11] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
262 Fikatas P, Lee JE, Sauer IM, Schmidt SC, Seehofer D, Puhl G, Guckelberger O. APACHE III score is superior to King’s College Hospital criteria, MELD score and APACHE II score to predict outcomes after liver transplantation for acute liver failure. Transplant Proc. 2013;45:2295-2301. [PMID: 23953541 DOI: 10.1016/j.transproceed.2013.02.125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
263 Lucena MI, Cohen H, Hernández N, Bessone F, Dacoll C, Stephens C, Borraz Y, Ulzurrun E, Bruguera M, Andrade RJ. Hepatotoxicidad, un problema global con especificidades locales: hacia la creación de una Red Hispano Latinoamericana de Hepatotoxicidad. Gastroenterología y Hepatología 2011;34:361-8. [DOI: 10.1016/j.gastrohep.2011.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
264 Yoshimaru K, Matsuura T, Yanagi Y, Takahashi Y, Kohashi K, Kaku N, Oda Y, Ohga S, Taguchi T. Successful Urgent Living Donor Liver Transplantation for Massive Liver Necrosis Accompanied by Nonocclusive Mesenteric Ischemia in a Biliary Atresia Infant: A Case Report. Transplant Proc 2020;52:2802-8. [PMID: 32713820 DOI: 10.1016/j.transproceed.2020.06.010] [Reference Citation Analysis]
265 Frontera JA, Kalb T. Neurological management of fulminant hepatic failure. Neurocrit Care 2011;14:318-27. [PMID: 21125349 DOI: 10.1007/s12028-010-9470-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
266 Kawaguchi T, Tominaga T. A Rare Case of Drug-Induced Liver Injury Caused by Levetiracetam. Asian J Neurosurg 2019;14:878-82. [PMID: 31497118 DOI: 10.4103/ajns.AJNS_246_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Rochling FA, Zetterman RK. Do Hepatotoxicity Registries Have a Role in Health Care? Gastroenterology 2008;135:1847-50. [DOI: 10.1053/j.gastro.2008.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
268 Alshuwaykh O, Kwong A, Goel A, Cheung A, Dhanasekaran R, Ahmed A, Daugherty T, Dronamraju D, Kumari R, Kim WR, Nguyen MH, Esquivel CO, Concepcion W, Melcher M, Bonham A, Pham T, Gallo A, Kwo PY. Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. Hepatol Commun 2021;5:516-25. [PMID: 33681683 DOI: 10.1002/hep4.1644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Church RJ, Kullak-Ublick GA, Aubrecht J, Bonkovsky HL, Chalasani N, Fontana RJ, Goepfert JC, Hackman F, King NMP, Kirby S, Kirby P, Marcinak J, Ormarsdottir S, Schomaker SJ, Schuppe-Koistinen I, Wolenski F, Arber N, Merz M, Sauer JM, Andrade RJ, van Bömmel F, Poynard T, Watkins PB. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort. Hepatology 2019;69:760-73. [PMID: 29357190 DOI: 10.1002/hep.29802] [Cited by in Crossref: 89] [Cited by in F6Publishing: 78] [Article Influence: 29.7] [Reference Citation Analysis]
270 Polson J, Lee WM. Etiologies of acute liver failure: location, location, location! Liver Transpl 2007;13:1362-3. [PMID: 17902141 DOI: 10.1002/lt.21144] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
271 El Hajj I, Sharara AI, Rockey DC. Subfulminant liver failure associated with quetiapine. Eur J Gastroenterol Hepatol. 2004;16:1415-1418. [PMID: 15618854 DOI: 10.1097/00042737-200412000-00029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
272 European Association for the Study of the Liver;  Clinical Practice Guideline Panel: Chair;  Panel members;  EASL Governing Board representative. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70:1222-1261. [PMID: 30926241 DOI: 10.1016/j.jhep.2019.02.014] [Cited by in Crossref: 198] [Cited by in F6Publishing: 149] [Article Influence: 99.0] [Reference Citation Analysis]
273 Laursen TL, Sandahl TD, Støy S, Schiødt FV, Lee WM, Vilstrup H, Thiel S, Grønbaek H; US Acute Liver Failure Study Group. Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure. Liver Int 2015;35:756-63. [PMID: 25203057 DOI: 10.1111/liv.12682] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
274 Mohamadi-zarch S, Baluchnejadmojarad T, Nourabadi D, Khanizadeh AM, Roghani M. Protective effect of diosgenin on LPS/D-Gal-induced acute liver failure in C57BL/6 mice. Microbial Pathogenesis 2020;146:104243. [DOI: 10.1016/j.micpath.2020.104243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
275 Lin X, Parks D, Painter J, Hunt CM, Stirnadel-farrant HA, Cheng J, Menius A, Lee K. Validation of Multivariate Outlier Detection Analyses Used to Identify Potential Drug-Induced Liver Injury in Clinical Trial Populations. Drug Saf 2012;35:865-75. [DOI: 10.1007/bf03261982] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
276 Ramappa V, Aithal GP. Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management. J Clin Exp Hepatol. 2013;3:37-49. [PMID: 25755470 DOI: 10.1016/j.jceh.2012.12.001] [Cited by in Crossref: 180] [Cited by in F6Publishing: 145] [Article Influence: 20.0] [Reference Citation Analysis]
277 Sivilotti ML, Green TJ, Langmann C, Yarema M, Juurlink D, Johnson D. Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose. Clinical Toxicology 2010;48:793-9. [DOI: 10.3109/15563650.2010.523829] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
278 Zapata R, Innocenti F, Sanhueza E, Humeres R, Rios H, Suarez L, Palacios J, Rius M, Hepp J. Clinical characterization and survival of adult patients awaiting liver transplantation in Chile. Transplantation Proceedings 2004;36:1669-70. [DOI: 10.1016/j.transproceed.2004.06.070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
279 Mellinger JL, Rossaro L, Naugler WE, Nadig SN, Appelman H, Lee WM, Fontana RJ. Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig Dis Sci 2014;59:1630-7. [PMID: 24464209 DOI: 10.1007/s10620-014-3029-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
280 Kathawala M, Hirschfield GM. Insights into the management of Wilson's disease. Therap Adv Gastroenterol. 2017;10:889-905. [PMID: 29147139 DOI: 10.1177/1756283x17731520] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
281 Parekh J, Matei VM, Canas-Coto A, Friedman D, Lee WM; Acute Liver Failure Study Group. Budd-chiari syndrome causing acute liver failure: A multicenter case series. Liver Transpl. 2017;23:135-142. [PMID: 27656864 DOI: 10.1002/lt.24643] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
282 Bolkhir A, Loiselle M, Evon D, Hayashi P. Depression in primary caregivers of patients listed for liver or kidney transplantation. Progress in Transplantation 2007;17:193-8. [DOI: 10.7182/prtr.17.3.bx6153k7040l7031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
283 Flynn NR, Dang NL, Ward MD, Swamidass SJ. XenoNet: Inference and Likelihood of Intermediate Metabolite Formation. J Chem Inf Model 2020;60:3431-49. [DOI: 10.1021/acs.jcim.0c00361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
284 Xu Q, Fan Y, Loor JJ, Liang Y, Sun X, Jia H, Zhao C, Xu C. Cardamonin Reduces Acetaminophen-Induced Acute Liver Injury in Mice via Activating Autophagy and NFE2L2 Signaling. Front Pharmacol 2020;11:601716. [PMID: 33364966 DOI: 10.3389/fphar.2020.601716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Singh D, Cho WC, Upadhyay G. Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview. Front Physiol 2015;6:363. [PMID: 26858648 DOI: 10.3389/fphys.2015.00363] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
286 Björnsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurologica Scandinavica 2008;118:281-90. [DOI: 10.1111/j.1600-0404.2008.01009.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
287 Frontera JA. Metabolic encephalopathies in the critical care unit. Continuum (Minneap Minn) 2012;18:611-39. [PMID: 22810252 DOI: 10.1212/01.CON.0000415431.07019.c2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
288 Bonkovsky HL, Barnhart HX, Foureau DM, Steuerwald N, Lee WM, Gu J, Fontana RJ, Hayashi PJ, Chalasani N, Navarro VM, Odin J, Stolz A, Watkins PB, Serrano J; US Drug-Induced Liver Injury Network and the Acute Liver Failure Study Group. Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group. PLoS One 2018;13:e0206389. [PMID: 30359443 DOI: 10.1371/journal.pone.0206389] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
289 Nalpas B, Ichaï P, Jamot L, Carbonell N, Rudler M, Mathurin P, Durand F, Gerken G, Manns M, Trautwein C, Larrey D, Radenne S, Duvoux C, Leroy V, Bernuau J, Faivre J, Moniaux N, Bréchot C, Amouyal G, Amouyal P, Samuel D. A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases. PLoS One 2016;11:e0150733. [PMID: 26983031 DOI: 10.1371/journal.pone.0150733] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
290 Myers DB, Highton TC, Rayns DG. Ruthenium red-positive filaments interconnecting collagen fibrils. J Ultrastruct Res 1973;42:87-92. [PMID: 4119259 DOI: 10.1016/s0022-5320(73)80008-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.1] [Reference Citation Analysis]
291 Jee A, Sernoskie SC, Uetrecht J. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges. Int J Mol Sci 2021;22:2954. [PMID: 33799477 DOI: 10.3390/ijms22062954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
292 Hoshino K, Nakamura Y, Nakano T, Watanabe A, Sheng H, Tachibana K, Ishikura H. Enhanced effect of recombinant human soluble thrombomodulin by ultrasound irradiation in acute liver failure. Sci Rep 2020;10:1742. [PMID: 32015385 DOI: 10.1038/s41598-020-58624-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
293 Hewitt NJ, Lechón MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna JG, Gustavsson L, Lohmann C, Skonberg C. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev. 2007;39:159-234. [PMID: 17364884 DOI: 10.1080/03602530601093489] [Cited by in Crossref: 542] [Cited by in F6Publishing: 471] [Article Influence: 38.7] [Reference Citation Analysis]
294 Rowden AK, Norvell J, Eldridge DL, Kirk MA. Acetaminophen Poisoning. Clinics in Laboratory Medicine 2006;26:49-65. [DOI: 10.1016/j.cll.2006.01.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
295 Davern TJ, Chalasani N. Drug-induced liver injury in clinical trials: as rare as hens' teeth. Am J Gastroenterol 2009;104:1159-61. [PMID: 19352346 DOI: 10.1038/ajg.2009.76] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
296 Iruzubieta P, Arias-Loste MT, Barbier-Torres L, Martinez-Chantar ML, Crespo J. The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role? Biomed Res Int 2015;2015:386186. [PMID: 26824035 DOI: 10.1155/2015/386186] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
297 Mobasher MA, Valverde ÁM. Signalling pathways involved in paracetamol-induced hepatotoxicity: new insights on the role of protein tyrosine phosphatase 1B. Archives of Physiology and Biochemistry 2014;120:51-63. [DOI: 10.3109/13813455.2014.893365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
298 Yeap V, Tan TJY, Loh T, Kumar R. Liver failure associated with mahogany seed extract consumption.BMJ Case Rep. 2018;bcr-2018. [PMID: 30061133 DOI: 10.1136/bcr-2018-225382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
299 Rowden AK, Norvell J, Eldridge DL, Kirk MA. Updates on Acetaminophen Toxicity. Medical Clinics of North America 2005;89:1145-59. [DOI: 10.1016/j.mcna.2005.06.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
300 Lewis JH, Kleiner DE. Hepatic injury due to drugs, herbal compounds, chemicals and toxins. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 645-760. [DOI: 10.1016/b978-0-7020-3398-8.00013-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
301 Su Kim H, Seon Kim H, Yoon Lee J, Sun Jang J, Geon Shin W, Ho Kim K, Yong Park J, Heon Lee J, Yang Kim H, Kuk Jang M. Initial thrombocytopenia as a simple, valuable predictor for clinical manifestation in acute hepatitis A. Scandinavian Journal of Gastroenterology 2009;43:81-8. [DOI: 10.1080/00365520701514578] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
302 Marroquin LD, Bonin PD, Keefer J, Schroeter T. Assessment of Bile Salt Export Pump (BSEP) Inhibition in Membrane Vesicles Using Radioactive and LC/MS‐Based Detection Methods. Current Protocols in Toxicology 2017;71. [DOI: 10.1002/cptx.15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
303 田丰, 解莹, 张亚杰. 肿瘤坏死因子-α、诱导性一氧化氮合酶在扑热息痛肝损害中的表达. 世界华人消化杂志 2012; 20(10): 818-823 [DOI: 10.11569/wcjd.v20.i10.818] [Reference Citation Analysis]
304 Urban TJ, Shen Y, Stolz A, Chalasani N, Fontana RJ, Rochon J, Ge D, Shianna KV, Daly AK, Lucena MI, Nelson MR, Molokhia M, Aithal GP, Floratos A, Pe'er I, Serrano J, Bonkovsky H, Davern TJ, Lee WM, Navarro VJ, Talwalkar JA, Goldstein DB, Watkins PB; Drug-Induced Liver Injury Network., DILIGEN., EUDRAGENE., Spanish DILI Registry., International Serious Adverse Events Consortium. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet Genomics 2012;22:784-95. [PMID: 22968431 DOI: 10.1097/FPC.0b013e3283589a76] [Cited by in Crossref: 90] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
305 Lodge JPA, Dasgupta D, Prasad KR, Attia M, Toogood GJ, Davies M, Millson C, Breslin N, Wyatt J, Robinson PJ, Bellamy MC, Snook N, Pollard SG. Emergency Subtotal Hepatectomy: A New Concept for Acetaminophen-Induced Acute Liver Failure: Temporary Hepatic Support by Auxiliary Orthotopic Liver Transplantation Enables Long-term Success. Annals of Surgery 2008;247:238-49. [DOI: 10.1097/sla.0b013e31816401ec] [Cited by in Crossref: 38] [Cited by in F6Publishing: 2] [Article Influence: 2.9] [Reference Citation Analysis]
306 Wolf MS, King J, Jacobson K, Di Francesco L, Bailey SC, Mullen R, McCarthy D, Serper M, Davis TC, Parker RM. Risk of unintentional overdose with non-prescription acetaminophen products. J Gen Intern Med. 2012;27:1587-1593. [PMID: 22638604 DOI: 10.1007/s11606-012-2096-3] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
307 Adams DH, Ju C, Ramaiah SK, Uetrecht J, Jaeschke H. Mechanisms of immune-mediated liver injury. Toxicol Sci. 2010;115:307-321. [PMID: 20071422 DOI: 10.1093/toxsci/kfq009] [Cited by in Crossref: 201] [Cited by in F6Publishing: 175] [Article Influence: 18.3] [Reference Citation Analysis]
308 Ghosh A, Berger I, Remien CH, Mubayi A. The role of alcohol consumption on acetaminophen induced liver injury: Implications from a mathematical model. J Theor Biol 2021;519:110559. [PMID: 33333080 DOI: 10.1016/j.jtbi.2020.110559] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
309 Zhang Y, Zhou ZW, Jin H, Hu C, He ZX, Yu ZL, Ko KM, Yang T, Zhang X, Pan SY, Zhou SF. Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity. Drug Des Devel Ther 2015;9:2001-27. [PMID: 25926716 DOI: 10.2147/DDDT.S77071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
310 Yeboah-Korang A, Louissaint J, Tsung I, Prabhu S, Fontana RJ. Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record. Drug Saf 2020;43:371-7. [PMID: 31916081 DOI: 10.1007/s40264-019-00903-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
311 Mohi-Ud-Din R, Mir RH, Sawhney G, Dar MA, Bhat ZA. Possible Pathways of Hepatotoxicity Caused by Chemical Agents. Curr Drug Metab 2019;20:867-79. [PMID: 31702487 DOI: 10.2174/1389200220666191105121653] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
312 Bolkhir A, Loiselle MM, Evon DM, Hayashi PH. Depression in Primary Caregivers of Patients Listed for Liver or Kidney Transplantation. Prog Transpl 2007;17:193-8. [DOI: 10.1177/152692480701700306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
313 Mann A, Pelz T, Rennert K, Mosig A, Decker M, Lupp A. Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substance. Hum Cell 2017;30:267-78. [PMID: 28527127 DOI: 10.1007/s13577-017-0175-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
314 Annunziata G, Mayuko I, Barbara M. Idiosyncratic Liver Injury Due to Levocetirizine. ACG Case Rep J 2019;6:e00191. [PMID: 31737721 DOI: 10.14309/crj.0000000000000191] [Reference Citation Analysis]
315 Aggarwal S, Brooks DM, Kang Y, Linden PK, Patzer JF. Noninvasive monitoring of cerebral perfusion pressure in patients with acute liver failure using transcranial doppler ultrasonography. Liver Transpl. 2008;14:1048-1057. [PMID: 18581484 DOI: 10.1002/lt.21499] [Cited by in Crossref: 84] [Cited by in F6Publishing: 49] [Article Influence: 6.5] [Reference Citation Analysis]
316 Vuppalanchi R, Liangpunsakul S, Chalasani N. Etiology of New-Onset Jaundice: How Often Is It Caused by Idiosyncratic Drug-Induced Liver Injury in The United States? Am J Gastroenterol 2007;102:558-62. [DOI: 10.1111/j.1572-0241.2006.01019.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 55] [Article Influence: 5.8] [Reference Citation Analysis]
317 Ramaiahgari SC, Waidyanatha S, Dixon D, DeVito MJ, Paules RS, Ferguson SS. From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening. Toxicol Sci 2017;159:124-36. [PMID: 28633424 DOI: 10.1093/toxsci/kfx122] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 16.0] [Reference Citation Analysis]
318 Davern TJ 2nd, James LP, Hinson JA, Polson J, Larson AM, Fontana RJ, Lalani E, Munoz S, Shakil AO, Lee WM; Acute Liver Failure Study Group. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology. 2006;130:687-694. [PMID: 16530510 DOI: 10.1053/j.gastro.2006.01.033] [Cited by in Crossref: 206] [Cited by in F6Publishing: 174] [Article Influence: 13.7] [Reference Citation Analysis]
319 Burra P. Management of complex liver diseases. Minerva Gastroenterol (Torino) 2021;67:2-3. [PMID: 33784806 DOI: 10.23736/S2724-5985.20.02803-2] [Reference Citation Analysis]
320 Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf. 2007;30:277-294. [PMID: 17408305 DOI: 10.2165/00002018-200730040-00001] [Cited by in Crossref: 197] [Cited by in F6Publishing: 170] [Article Influence: 14.1] [Reference Citation Analysis]
321 Elzagallaai AA, Rieder MJ. In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology. Br J Clin Pharmacol 2015;80:889-900. [PMID: 25199801 DOI: 10.1111/bcp.12505] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
322 Kesavarapu K, Kang M, Shin JJ, Rothstein K. Yogi Detox Tea: A Potential Cause of Acute Liver Failure. Case Rep Gastrointest Med. 2017;2017:3540756. [PMID: 29204300 DOI: 10.1155/2017/3540756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
323 Ogier JM, Nayagam BA, Lockhart PJ. ASK1 inhibition: a therapeutic strategy with multi-system benefits. J Mol Med (Berl) 2020;98:335-48. [PMID: 32060587 DOI: 10.1007/s00109-020-01878-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
324 Putignano A, Figorilli F, Alabsawy E, Agarwal B, Jalan R. Long-term outcome in patients with acute liver failure. Liver Int 2018;38:2228-38. [DOI: 10.1111/liv.13914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
325 Mohsenin V. Assessment and management of cerebral edema and intracranial hypertension in acute liver failure. Journal of Critical Care 2013;28:783-91. [DOI: 10.1016/j.jcrc.2013.04.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
326 Thomas KC, Wilkins DG, Curry SC, Grey TC, Andrenyak DM, McGill LD, Rollins DE. Detection of Acetaminophen-Protein Adducts in Decedents with Suspected Opioid-Acetaminophen Combination Product Overdose. J Forensic Sci 2016;61:1301-6. [PMID: 27479586 DOI: 10.1111/1556-4029.13169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
327 Smith ID, Simpson KJ, Garden OJ, Wigmore SJ. Non-paracetamol drug-induced fulminant hepatic failure among adults in Scotland. Eur J Gastroenterol Hepatol 2005;17:161-7. [PMID: 15674093 DOI: 10.1097/00042737-200502000-00006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
328 Frontera JA. Management of hepatic encephalopathy. Curr Treat Options Neurol. 2014;16:297. [PMID: 24807164 DOI: 10.1007/s11940-014-0297-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
329 Holt EW, Demartini S, Davern TJ. Acute Liver Failure Due to Acetaminophen Poisoning in Patients With Prior Weight Loss Surgery: A Case Series. Journal of Clinical Gastroenterology 2015;49:790-3. [DOI: 10.1097/mcg.0000000000000278] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
330 Ichai P, Samuel D. Epidemiology of liver failure. Clinics and Research in Hepatology and Gastroenterology 2011;35:610-7. [DOI: 10.1016/j.clinre.2011.03.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
331 Becker MW, Lunardelli MJM, Tovo CV, Blatt CR. Drug and herb-induced liver injury: A critical review of Brazilian cases with proposals for the improvement of causality assessment using RUCAM. Ann Hepatol. 2019;18:742-750. [PMID: 31130470 DOI: 10.1016/j.aohep.2019.03.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
332 Lee WM, Senior JR. Recognizing drug-induced liver injury: current problems, possible solutions. Toxicol Pathol. 2005;33:155-164. [PMID: 15805067 DOI: 10.1080/01926230590522356] [Cited by in Crossref: 131] [Cited by in F6Publishing: 109] [Article Influence: 8.2] [Reference Citation Analysis]
333 Muriel P. The Liver. Liver Pathophysiology. Elsevier; 2017. pp. 3-22. [DOI: 10.1016/b978-0-12-804274-8.00001-1] [Cited by in Crossref: 10] [Article Influence: 2.5] [Reference Citation Analysis]
334 Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W. FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today. 2011;16:697-703. [PMID: 21624500 DOI: 10.1016/j.drudis.2011.05.007] [Cited by in Crossref: 245] [Cited by in F6Publishing: 207] [Article Influence: 24.5] [Reference Citation Analysis]
335 Ahmed NZ, Agibothu Kupparam HK, Akbar S, Hissar S, Anwar N, Thiruvengadam K, Anjum N, Khan AA, Dar S, Natarajan S. Effects of co-administration of Unani pharmacopoeia formulations Qurs Tabasheer Sartani and Arq Hara Bhara with CAT-I antitubercular drugs in rats. J Complement Integr Med 2021. [PMID: 33964191 DOI: 10.1515/jcim-2020-0262] [Reference Citation Analysis]
336 García-Cortés M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, Andrade RJ. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther. 2008;27:780-789. [PMID: 18284654 DOI: 10.1111/j.1365-2036.2008.03655.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 7.9] [Reference Citation Analysis]
337 Lee WM. Drug-induced acute liver failure. Clin Liver Dis 2013;17:575-86, viii. [PMID: 24099019 DOI: 10.1016/j.cld.2013.07.001] [Cited by in Crossref: 133] [Cited by in F6Publishing: 106] [Article Influence: 16.6] [Reference Citation Analysis]
338 Davern TJ. Drug-induced liver disease. Clin Liver Dis. 2012;16:231-245. [PMID: 22541696 DOI: 10.1016/j.cld.2012.03.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
339 Hay JE. Acute Liver Failure. Curr Treat Options Gastroenterol 2004;7:459-68. [PMID: 15527712 DOI: 10.1007/s11938-004-0005-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
340 Mishra A, Rustgi V. Prognostic Models in Acute Liver Failure. Clin Liver Dis. 2018;22:375-388. [PMID: 29605072 DOI: 10.1016/j.cld.2018.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
341 Hessheimer AJ, Nacif L, Flores Villalba E, Fondevila C. Liver transplantation for acute liver failure. Cir Esp 2017;95:181-9. [PMID: 28433231 DOI: 10.1016/j.ciresp.2017.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
342 Munoz SJ, Rajender Reddy K, Lee W. The coagulopathy of acute liver failure and implications for intracranial pressure monitoring. Neurocrit Care. 2008;9:103-107. [PMID: 18379899 DOI: 10.1007/s12028-008-9087-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
343 Shinohara M, Ybanez MD, Win S, Than TA, Jain S, Gaarde WA, Han D, Kaplowitz N. Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1. J Biol Chem 2010;285:8244-55. [PMID: 20061376 DOI: 10.1074/jbc.M109.054999] [Cited by in Crossref: 85] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
344 Khanna A, Hemming AW. Fulminant hepatic failure: when to transplant. Surg Clin North Am 2010;90:877-89. [PMID: 20637954 DOI: 10.1016/j.suc.2010.04.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
345 Anwar I, Ashfaq UA, Shokat Z. Therapeutic Potential of Umbilical Cord Stem Cells for Liver Regeneration. Curr Stem Cell Res Ther 2020;15:219-32. [PMID: 32077830 DOI: 10.2174/1568026620666200220122536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
346 Brophy CM, Nyberg SL. Extracorporeal treatment of acute liver failure. Hepatol Res 2008;38 Suppl 1:S34-40. [PMID: 19125950 DOI: 10.1111/j.1872-034X.2008.00424.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
347 Uetrecht J. Role of the Adaptive Immune System in Idiosyncratic Drug-Induced Liver Injury. Drug-Induced Liver Disease. Elsevier; 2013. pp. 175-93. [DOI: 10.1016/b978-0-12-387817-5.00011-x] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
348 Wong A, Sivilotti MLA, Dargan PI, Wood DM, Greene SL. External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clinical Toxicology 2015;53:807-14. [DOI: 10.3109/15563650.2015.1066507] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
349 Li X, Gao P, Niu J. Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury. Biomed Res Int 2019;2019:8764093. [PMID: 31531370 DOI: 10.1155/2019/8764093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
350 Jennings P, Schwarz M, Landesmann B, Maggioni S, Goumenou M, Bower D, Leonard MO, Wiseman JS. SEURAT-1 liver gold reference compounds: a mechanism-based review. Arch Toxicol 2014;88:2099-133. [DOI: 10.1007/s00204-014-1410-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
351 Shi Y, Zhang L, Jiang R, Chen W, Zheng W, Chen L, Tang L, Li L, Li L, Tang W, Wang Y, Yu Y. Protective effects of nicotinamide against acetaminophen-induced acute liver injury. Int Immunopharmacol 2012;14:530-7. [PMID: 23059795 DOI: 10.1016/j.intimp.2012.09.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
352 Jeong R, Lee YS, Sohn C, Jeon J, Ahn S, Lim KS. Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury. Scand J Gastroenterol. 2015;50:439-446. [PMID: 25639449 DOI: 10.3109/00365521.2014.958094] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
353 Björnsson ES. Global Epidemiology of Drug-Induced Liver Injury (DILI). Curr Hepatology Rep 2019;18:274-9. [DOI: 10.1007/s11901-019-00475-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
354 Im SG, Yoo SH, Jeon DO, Cho HJ, Choi JY, Paik S, Park YM. Chelidonium majus -Induced Acute Hepatitis. Ewha Med J 2014;37:60. [DOI: 10.12771/emj.2014.37.1.60] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
355 Kumar R, Bhatia V, Khanal S, Sreenivas V, Gupta SD, Panda SK, Acharya SK; Shalimar. Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome. Hepatology 2010;51:1665-74. [PMID: 20196116 DOI: 10.1002/hep.23534] [Cited by in Crossref: 91] [Cited by in F6Publishing: 73] [Article Influence: 8.3] [Reference Citation Analysis]
356 Shin SM, Yang JH, Ki SH. Role of the Nrf2-ARE pathway in liver diseases. Oxid Med Cell Longev. 2013;2013:763257. [PMID: 23766860 DOI: 10.1155/2013/763257] [Cited by in Crossref: 99] [Cited by in F6Publishing: 108] [Article Influence: 12.4] [Reference Citation Analysis]
357 Tan CY, Saw TY, Fong CW, Ho HK. Comparative hepatoprotective effects of tocotrienol analogs against drug-induced liver injury. Redox Biol 2015;4:308-20. [PMID: 25637740 DOI: 10.1016/j.redox.2015.01.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
358 Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf. 2007;6:673-684. [PMID: 17967156 DOI: 10.1517/14740338.6.6.673] [Cited by in Crossref: 121] [Cited by in F6Publishing: 101] [Article Influence: 8.6] [Reference Citation Analysis]
359 Abou Seif HS. Physiological changes due to hepatotoxicity and the protective role of some medicinal plants. Beni-Suef University Journal of Basic and Applied Sciences 2016;5:134-46. [DOI: 10.1016/j.bjbas.2016.03.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 4.2] [Reference Citation Analysis]
360 Alqahtani SA, Larson AM. Adult liver transplantation in the USA: . Current Opinion in Gastroenterology 2011;27:240-7. [DOI: 10.1097/mog.0b013e3283457d5d] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
361 Oda S, Uchida Y, Aleo MD, Koza-Taylor PH, Matsui Y, Hizue M, Marroquin LD, Whritenour J, Uchida E, Yokoi T. An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol 2021;95:149-68. [PMID: 32816093 DOI: 10.1007/s00204-020-02882-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
362 Brennan PN, Donnelly MC, Simpson KJ. Systematic review: non A-E, seronegative or indeterminate hepatitis; what is this deadly disease? Aliment Pharmacol Ther 2018;47:1079-91. [PMID: 29468698 DOI: 10.1111/apt.14566] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
363 Kim YR, Lee NJ, Ban JO, Yoo HS, Lee YM, Yoon YP, Eum SY, Jeong HS, Yoon DY, Han SB, Hong JT. Curative Effects of Thiacremonone against Acetaminophen-Induced Acute Hepatic Failure via Inhibition of Proinflammatory Cytokines Production and Infiltration of Cytotoxic Immune Cells and Kupffer Cells. Evid Based Complement Alternat Med 2013;2013:974794. [PMID: 23935693 DOI: 10.1155/2013/974794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
364 Carneiro de Moura M, Marinho R. [Natural history and clinical manifestations of chronic hepatitis B virus]. Enferm Infecc Microbiol Clin 2008;26 Suppl 7:11-8. [PMID: 19100227 DOI: 10.1016/s0213-005x(08)76515-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
365 Warrillow SJ, Bellomo R. Preventing cerebral oedema in acute liver failure: the case for quadruple-H therapy. Anaesth Intensive Care. 2014;42:78-88. [PMID: 24471667 DOI: 10.1177/0310057x1404200114] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 2.4] [Reference Citation Analysis]
366 Ng S, Han R, Chang S, Ni J, Hunziker W, Goryachev AB, Ong SH, Yu H. Improved Hepatocyte Excretory Function by Immediate Presentation of Polarity Cues. Tissue Engineering 2006;0:060913044658033. [DOI: 10.1089/ten.2006.12.ft-169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
367 Hoyer DP, Munteanu M, Canbay A, Hartmann M, Gallinat A, Paul A, Saner FH. Liver transplantation for acute liver failure: are there thresholds not to be crossed? Transpl Int. 2014;27:625-633. [PMID: 24606197 DOI: 10.1111/tri.12302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
368 Cui YL, Meng MB, Tang H, Zheng MH, Wang YB, Han HX, Lei XZ. Recombinant human hepatocyte growth factor for liver failure. Contemp Clin Trials 2008;29:696-704. [PMID: 18554990 DOI: 10.1016/j.cct.2008.04.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
369 Das AK, Begum T, Kar P, Dutta A. Profile of Acute Liver Failure from North-east India and Its Differences from other Parts of the Country. Euroasian J Hepatogastroenterol. 2016;6:111-115. [PMID: 29201741 DOI: 10.5005/jp-journals-10018-1181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
370 Rich NE, Sanders C, Hughes RS, Fontana RJ, Stravitz RT, Fix O, Han SH, Naugler WE, Zaman A, Lee WM. Malignant infiltration of the liver presenting as acute liver failure. Clin Gastroenterol Hepatol 2015;13:1025-8. [PMID: 25277846 DOI: 10.1016/j.cgh.2014.09.040] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
371 Santos Júnior GO, Ferreira Filho RP, Foulon LMDC, Noblat LDACB. Fulminant hepatic failure caused by herbal supplies. Braz J Pharm Sci 2018;54. [DOI: 10.1590/s2175-97902018000317418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
372 Bernuau J, Durand F. Early prediction of encephalopathy in hospitalized patients with severe acute liver disease: The narrow window of opportunity for transplant-free survival. Journal of Hepatology 2009;51:977-80. [DOI: 10.1016/j.jhep.2009.09.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
373 Lat I, Foster DR, Erstad B. Drug-induced acute liver failure and gastrointestinal complications. Crit Care Med. 2010;38:S175-S187. [PMID: 20502172 DOI: 10.1097/ccm.0b013e3181de0db2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
374 Chen SS, Yu KK, Huang C, Li N, Zheng JM, Bao SX, Chen MQ, Zhang WH. The characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study. Medicine (Baltimore) 2016;95:e4683. [PMID: 27559976 DOI: 10.1097/MD.0000000000004683] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
375 Kim JD, Cho EJ, Ahn C, Park SK, Choi JY, Lee HC, Kim DY, Choi MS, Wang HJ, Kim IH, Yeon JE, Seo YS, Tak WY, Kim MY, Lee HJ, Kim YS, Jun DW, Sohn JH, Kwon SY, Park SH, Heo J, Jeong SH, Lee JH, Nakayama N, Mochida S, Ido A, Tsubouchi H, Takikawa H, Shalimar, Acharya SK, Bernal W, O'Grady J, Kim YJ. A Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure. Hepatology. 2019;70:621-629. [PMID: 30194739 DOI: 10.1002/hep.30262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
376 Margulis E, Dagan-Wiener A, Ives RS, Jaffari S, Siems K, Niv MY. Intense bitterness of molecules: Machine learning for expediting drug discovery. Comput Struct Biotechnol J 2021;19:568-76. [PMID: 33510862 DOI: 10.1016/j.csbj.2020.12.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
377 Hunt CM, Forster JK, Papay JI, Stirnadel HA. Evidence-Based Liver Chemistry Monitoring in Drug Development. Pharm Med 2009;23:149-58. [DOI: 10.1007/bf03256763] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
378 Thompson RA, Isin EM, Ogese MO, Mettetal JT, Williams DP. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments. Chem Res Toxicol 2016;29:505-33. [DOI: 10.1021/acs.chemrestox.5b00410] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 15.8] [Reference Citation Analysis]
379 Trotter JF. Practical management of acute liver failure in the intensive care unit: . Current Opinion in Critical Care 2009;15:163-7. [DOI: 10.1097/mcc.0b013e3283293114] [Cited by in Crossref: 26] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
380 Kuzu UB, Öztaş E, Turhan N, Saygili F, Suna N, Yildiz H, Kaplan M, Akpinar MY, Akdoğan M, Kaçar S, Kiliç ZM, Köksal AŞ, Ödemiş B, Kayaçetin E. Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis. Hepatol Res 2016;46:277-91. [PMID: 25926402 DOI: 10.1111/hepr.12530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
381 Cainelli F, Nardo B, Viderman D, Dzudzor B, Tachi K, Vento S. Treatment of Acute Liver Failure in Resource-Constrained Settings without Transplantation Facilities Can Be Improved. Front Med (Lausanne) 2016;3:31. [PMID: 27458585 DOI: 10.3389/fmed.2016.00031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
382 Squires RH, Dhawan A, Alonso E, Narkewicz MR, Shneider BL, Rodriguez-Baez N, Olio DD, Karpen S, Bucuvalas J, Lobritto S. Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology. 2013;57:1542-1549. [PMID: 22886633 DOI: 10.1002/hep.26001] [Cited by in Crossref: 94] [Cited by in F6Publishing: 68] [Article Influence: 11.8] [Reference Citation Analysis]
383 Mcgill MR, Cao M, Svetlov A, Sharpe MR, Williams CD, Curry SC, Farhood A, Jaeschke H, Svetlov SI. Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans. Biomarkers 2014;19:222-30. [DOI: 10.3109/1354750x.2014.897757] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
384 Wendon J, Cordoba J, Dhawan A, Larsen FS, Manns M, Nevens F, Samuel D, Simpson KJ, Yaron I, Bernardi M. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. Journal of Hepatology 2017;66:1047-81. [DOI: 10.1016/j.jhep.2016.12.003] [Cited by in Crossref: 280] [Cited by in F6Publishing: 221] [Article Influence: 70.0] [Reference Citation Analysis]
385 Kim SY, Kim BH, Dong SH, Kim HJ, Chang YW, Chang R, Kim YW. Alfuzosin-induced acute liver injury. Korean J Hepatol 2007;13:414-8. [PMID: 17898558 DOI: 10.3350/kjhep.2007.13.3.414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
386 Tracy B, Shrestha R, Stein L, Bhasin D, Pollinger H, Rubin RA. Liver transplantation for fulminant genotype 2a/c hepatitis C virus marked by a rapid recurrence followed by cure. Transpl Infect Dis 2017;19. [PMID: 28273391 DOI: 10.1111/tid.12690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
387 Fontana RJ, Ellerbe C, Durkalski VE, Rangnekar A, Reddy RK, Stravitz T, McGuire B, Davern T, Reuben A, Liou I, Fix O, Ganger DR, Chung RT, Schilsky M, Han S, Hynan LS, Sanders C, Lee WM; US Acute Liver Failure Study Group. Two-year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study. Liver Int 2015;35:370-80. [PMID: 25039930 DOI: 10.1111/liv.12632] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
388 Ke L, Lu C, Shen R, Lu T, Ma B, Hua Y. Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010-2019). Front Pharmacol 2020;11:842. [PMID: 32581801 DOI: 10.3389/fphar.2020.00842] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
389 da Rocha BA, Ritter AMV, Ames FQ, Gonçalves OH, Leimann FV, Bracht L, Natali MRM, Cuman RKN, Bersani-amado CA. Acetaminophen-induced hepatotoxicity: Preventive effect of trans anethole. Biomedicine & Pharmacotherapy 2017;86:213-20. [DOI: 10.1016/j.biopha.2016.12.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
390 Akamatsu N, Sugawara Y. Acute liver failure and living donor liver transplantation. Hepatology Research 2008;38:S60-71. [DOI: 10.1111/j.1872-034x.2008.00429.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
391 Ndekwe P, Ghabril MS, Zang Y, Mann SA, Cummings OW, Lin J. Substantial hepatic necrosis is prognostic in fulminant liver failure. World J Gastroenterol 2017; 23(23): 4303-4310 [PMID: 28694671 DOI: 10.3748/wjg.v23.i23.4303] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
392 Hernández N, Bessone F, Sánchez A, Pace MD, Brahm J, Zapata R, Chirino RA, Dávalos M, Méndez-sánchez N, Arrese M, Schinoni M, Lucena MI, Andrade RJ. Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports. Annals of Hepatology 2014;13:231-9. [DOI: 10.1016/s1665-2681(19)30886-5] [Cited by in Crossref: 22] [Article Influence: 3.1] [Reference Citation Analysis]
393 Leise MD, Poterucha JJ, Talwalkar JA. Drug-induced liver injury. Mayo Clin Proc. 2014;89:95-106. [PMID: 24388027 DOI: 10.1016/j.mayocp.2013.09.016] [Cited by in Crossref: 208] [Cited by in F6Publishing: 185] [Article Influence: 29.7] [Reference Citation Analysis]
394 Goyal RK, Srivastava D, Lessnau K. Clopidogrel-Induced Hepatocellular Injury and Cholestatic Jaundice in an Elderly Patient: Case Report and Review of the Literature. Pharmacotherapy 2009;29:608-12. [DOI: 10.1592/phco.29.5.608] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
395 Bell CC, Lauschke VM, Vorrink SU, Palmgren H, Duffin R, Andersson TB, Ingelman-Sundberg M. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury. Drug Metab Dispos 2017;45:419-29. [PMID: 28137721 DOI: 10.1124/dmd.116.074369] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 24.0] [Reference Citation Analysis]
396 McCarberg B, Gibofsky A. Need to develop new nonsteroidal anti-inflammatory drug formulations. Clin Ther 2012;34:1954-63. [PMID: 22939163 DOI: 10.1016/j.clinthera.2012.08.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
397 Zhang Y, Luo JX, Hu XY, Yang F, Zhong S, Lin W. Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats. World J Gastroenterol 2016; 22(8): 2558-2565 [PMID: 26937143 DOI: 10.3748/wjg.v22.i8.2558] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
398 Kumar R, Bhatia V. Structured approach to treat patients with acute liver failure: A hepatic emergency. Indian J Crit Care Med. 2012;16:1-7. [PMID: 22557825 DOI: 10.4103/0972-5229.94409] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
399 Dargan PI, Jones AL. Management of paracetamol poisoning. Trends in Pharmacological Sciences 2003;24:154-7. [DOI: 10.1016/s0165-6147(03)00053-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
400 Lee CH, Wang JD, Chen PC. Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs. Pharmacoepidemiol Drug Saf 2010;19:708-14. [PMID: 20582911 DOI: 10.1002/pds.1966] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
401 Beersma MF, Verjans GM, Metselaar HJ, Osterhaus AD, Berrington WR, van Doornum GJ. Quantification of viral DNA and liver enzymes in plasma improves early diagnosis and management of herpes simplex virus hepatitis. J Viral Hepat. 2011;18:e160-e166. [PMID: 20704650 DOI: 10.1111/j.1365-2893.2010.01352.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
402 Buechter M, Gerken G, Hoyer DP, Bertram S, Theysohn JM, Thodou V, Kahraman A. Liver maximum capacity (LiMAx) test as a helpful prognostic tool in acute liver failure with sepsis: a case report. BMC Anesthesiol 2018;18:71. [PMID: 29925334 DOI: 10.1186/s12871-018-0538-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
403 Sales I, Dzierba AL, Smithburger PL, Rowe D, Kane-gill SL. Use of acetylcysteine for non-acetaminophen-induced acute liver failure. Annals of Hepatology 2013;12:6-10. [DOI: 10.1016/s1665-2681(19)31379-1] [Cited by in Crossref: 23] [Article Influence: 2.9] [Reference Citation Analysis]
404 Kuznietsova H, Lynchak O, Dziubenko N, Herheliuk T, Prylutskyy Y, Rybalchenko V, Ritter U. Water-soluble pristine C60 fullerene attenuates acetaminophen-induced liver injury. Bioimpacts 2019;9:227-37. [PMID: 31799159 DOI: 10.15171/bi.2019.28] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
405 Masson MJ, Collins LA, Carpenter LD, Graf ML, Ryan PM, Bourdi M, Pohl LR. Pathologic role of stressed-induced glucocorticoids in drug-induced liver injury in mice. Biochem Biophys Res Commun 2010;397:453-8. [PMID: 20510877 DOI: 10.1016/j.bbrc.2010.05.126] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
406 Luber RP, Rentsch C, Lontos S, Pope JD, Aung AK, Schneider HG, Kemp W, Roberts SK, Majeed A. Turmeric induced liver injury: A report of two cases. Case Reports Hepatol. 2019;2019:6741213. [PMID: 31214366 DOI: 10.1155/2019/6741213] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
407 Singhal S, Chakravarty A, Das BC, Kar P. Tumour necrosis factor-alpha and soluble Fas ligand as biomarkers in non-acetaminophen-induced acute liver failure. Biomarkers. 2009;14:347-353. [PMID: 19505222 DOI: 10.1080/13547500903013664] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
408 Kim CW, Park JS, Oh SH, Park JH, Shim HI, Yoon JW, Park JS, Hong SB, Kim JM, Le TB, Lee JW. Drug-induced liver injury caused by iodine-131. Clin Mol Hepatol 2016;22:272-5. [PMID: 27209646 DOI: 10.3350/cmh.2015.0037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
409 Assis DN, Navarro VJ. Human drug hepatotoxicity: a contemporary clinical perspective. Expert Opin Drug Metab Toxicol 2009;5:463-73. [PMID: 19416083 DOI: 10.1517/17425250902927386] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
410 Mallet M, Weiss N, Thabut D, Rudler M. Why and when to measure ammonemia in cirrhosis? Clin Res Hepatol Gastroenterol 2018;42:505-11. [PMID: 29551609 DOI: 10.1016/j.clinre.2018.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
411 Fontana RJ, Engle RE, Scaglione S, Araya V, Shaikh O, Tillman H, Attar N, Purcell RH, Lee WM;  US Acute Liver Failure Study Group. The role of hepatitis E virus infection in adult Americans with acute liver failure. Hepatology. 2016;64:1870-1880. [PMID: 27215797 DOI: 10.1002/hep.28649] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 9.4] [Reference Citation Analysis]
412 Park BK, Boobis A, Clarke S, Goldring CEP, Jones D, Kenna JG, Lambert C, Laverty HG, Naisbitt DJ, Nelson S, Nicoll-griffith DA, Obach RS, Routledge P, Smith DA, Tweedie DJ, Vermeulen N, Williams DP, Wilson ID, Baillie TA. Managing the challenge of chemically reactive metabolites in drug development. Nat Rev Drug Discov 2011;10:292-306. [DOI: 10.1038/nrd3408] [Cited by in Crossref: 324] [Cited by in F6Publishing: 279] [Article Influence: 32.4] [Reference Citation Analysis]
413 Gao Y, Li JT, Li X, Li X, Yang SW, Chen NH, Li L, Zhang L. Tetrahydroxy stilbene glycoside attenuates acetaminophen-induced hepatotoxicity by UHPLC-Q-TOF/MS-based metabolomics and multivariate data analysis. J Cell Physiol 2021;236:3832-62. [PMID: 33111343 DOI: 10.1002/jcp.30127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
414 Dmello D, Cruz-Flores S, Matuschak GM. Moderate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: a systematic review. Intensive Care Med. 2010;36:210-213. [PMID: 19847396 DOI: 10.1007/s00134-009-1702-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
415 Narkewicz MR, Dell Olio D, Karpen SJ, Murray KF, Schwarz K, Yazigi N, Zhang S, Belle SH, Squires RH; Pediatric Acute Liver Failure Study Group. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr 2009;155:801-806.e1. [PMID: 19643443 DOI: 10.1016/j.jpeds.2009.06.005] [Cited by in Crossref: 92] [Cited by in F6Publishing: 61] [Article Influence: 7.7] [Reference Citation Analysis]
416 Kurokohchi K, Imataki O, Kubo F. Anti-inflammatory effect of recombinant thrombomodulin for fulminant hepatic failure. World J Gastroenterol 2015; 21(26): 8203-8207 [PMID: 26185395 DOI: 10.3748/wjg.v21.i26.8203] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
417 Antoine DJ, Williams DP, Park BK. Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science. Expert Opin Drug Metab Toxicol 2008;4:1415-27. [PMID: 18950283 DOI: 10.1517/17425255.4.11.1415] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
418 Stevens RD, Merritt WT. Rescuing the brain in acute liver failure*: . Critical Care Medicine 2008;36:2212-3. [DOI: 10.1097/ccm.0b013e31817e255c] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
419 Porceddu M, Buron N, Roussel C, Labbe G, Fromenty B, Borgne-Sanchez A. Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria. Toxicol Sci 2012;129:332-45. [PMID: 22987451 DOI: 10.1093/toxsci/kfs197] [Cited by in Crossref: 126] [Cited by in F6Publishing: 29] [Article Influence: 15.8] [Reference Citation Analysis]
420 Mitchell SJ, Kane AE, Hilmer SN. Age-related changes in the hepatic pharmacology and toxicology of paracetamol. Curr Gerontol Geriatr Res 2011;2011:624156. [PMID: 21765826 DOI: 10.1155/2011/624156] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
421 Chandrasekaran VRM, Wan C, Liu L, Hsu D, Liu M. EFFECT OF SESAME OIL AGAINST ACETAMINOPHEN-INDUCED ACUTE OXIDATIVE HEPATIC DAMAGE IN RATS. Shock 2008;30:217-21. [DOI: 10.1097/shk.0b013e318160dd6b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
422 Uysal HB, Dağlı B, Yılmaz M, Kahyaoğlu F, Gökçimen A, Ömürlü İK, Demirci B. Biochemical and Histological Effects of Thiamine Pyrophosphate against Acetaminophen-Induced Hepatotoxicity. Basic Clin Pharmacol Toxicol 2016;118:70-6. [DOI: 10.1111/bcpt.12496] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
423 Simões C, Santos S, Vicente M, Sousa Cardoso F. Epidemiology of Acute Liver Failure from a Regional Liver Transplant Center in Portugal. GE Port J Gastroenterol 2018;26:33-9. [PMID: 30675502 DOI: 10.1159/000487312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
424 Sjogren M. Immunization and the decline of viral hepatitis as a cause of acute liver failure. Hepatology 2003;38:554-6. [PMID: 12939580 DOI: 10.1053/jhep.2003.50401] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
425 Larrey D. Y a t-il un risque à prescrire du paracétamol chez des malades atteints d’hépatopathies aiguës ou chroniques ? Gastroentérologie Clinique et Biologique 2006;30:753-5. [DOI: 10.1016/s0399-8320(06)73309-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
426 Lazerow SK, Abdi MS, Lewis JH. Drug-induced liver disease 2004. Curr Opin Gastroenterol. 2005;21:283-292. [PMID: 15818148 DOI: 10.1097/01.mog.0000160043.10804.60] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
427 Au JS, Navarro VJ, Rossi S. Review article: Drug-induced liver injury--its pathophysiology and evolving diagnostic tools. Aliment Pharmacol Ther. 2011;34:11-20. [PMID: 21539586 DOI: 10.1111/j.1365-2036.2011.04674.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 7.6] [Reference Citation Analysis]
428 Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB, Hayashi PH, Davern TJ, Navarro V, Reddy R, Talwalkar JA, Stolz A, Gu J, Barnhart H, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN). Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology. 2014;59:661-670. [PMID: 24037963 DOI: 10.1002/hep.26709] [Cited by in Crossref: 212] [Cited by in F6Publishing: 181] [Article Influence: 26.5] [Reference Citation Analysis]
429 Cramer JD, Barnett ML, Anne S, Bateman BT, Rosenfeld RM, Tunkel DE, Brenner MJ. Nonopioid, Multimodal Analgesia as First-line Therapy After Otolaryngology Operations: Primer on Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Otolaryngol Head Neck Surg 2021;164:712-9. [PMID: 32806991 DOI: 10.1177/0194599820947013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
430 Štuhec M. Agomelatine-induced hepatotoxicity. Wien Klin Wochenschr 2013;125:225-6. [PMID: 23519541 DOI: 10.1007/s00508-013-0344-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
431 Daly FF, Fountain JS, Murray L, Graudins A, Buckley NA; Panel of Australian and New Zealand clinical toxicologists. Guidelines for the management of paracetamol poisoning in Australia and New Zealand--explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust 2008;188:296-301. [PMID: 18312195 DOI: 10.5694/j.1326-5377.2008.tb01625.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 100] [Article Influence: 9.2] [Reference Citation Analysis]
432 Qiu LL, Wang C, Yao S, Li N, Hu Y, Yu Y, Xia R, Zhu J, Ji M, Zhang Z, Wang SL. Fenvalerate induces oxidative hepatic lesions through an overload of intracellular calcium triggered by the ERK/IKK/NF-κB pathway. FASEB J 2019;33:2782-95. [PMID: 30307764 DOI: 10.1096/fj.201801289R] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
433 Ichaï P, Saliba F. [Fulminant and subfulminant hepatitis: causes and treatment]. Presse Med 2009;38:1290-8. [PMID: 19574022 DOI: 10.1016/j.lpm.2009.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
434 Nguyen KD, Sundaram V, Ayoub WS. Atypical causes of cholestasis. World J Gastroenterol 2014; 20(28): 9418-9426 [PMID: 25071336 DOI: 10.3748/wjg.v20.i28.9418] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
435 Forde KA, Reddy KR, Troxel AB, Sanders CM, Lee WM; Acute Liver Failure Study Group. Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States. Clin Gastroenterol Hepatol 2009;7:1121-6. [PMID: 19501192 DOI: 10.1016/j.cgh.2009.05.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
436 Salas JR, Chen BY, Wong A, Duarte S, Angarita SAK, Lipshutz GS, Witte ON, Clark PM. Noninvasive Imaging of Drug-Induced Liver Injury with 18F-DFA PET. J Nucl Med 2018;59:1308-15. [PMID: 29496991 DOI: 10.2967/jnumed.117.206961] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
437 Abd El-Hack ME, Samak DH, Noreldin AE, El-Naggar K, Abdo M. Probiotics and plant-derived compounds as eco-friendly agents to inhibit microbial toxins in poultry feed: a comprehensive review. Environ Sci Pollut Res Int 2018;25:31971-86. [PMID: 30229484 DOI: 10.1007/s11356-018-3197-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
438 Lucena MI, L??pez-torres E, Verge C, Andrade RJ, Puche MJ, Seoane J, de la Cuesta FS. The administration of N-acetylcysteine causes a decrease in prothrombin time in patients with paracetamol overdose but without evidence of liver impairment: . European Journal of Gastroenterology & Hepatology 2005;17:59-63. [DOI: 10.1097/00042737-200501000-00012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
439 Schiødt FV, Bangert K, Shakil AO, McCashland T, Murray N, Hay JE, Lee WM. Predictive value of actin-free Gc-globulin in acute liver failure. Liver Transpl. 2007;13:1324-1329. [PMID: 17763387 DOI: 10.1002/lt.21236] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
440 Ash MM, Jolly PS. Cholestatic hepatic injury associated with vismodegib, aspirin, and naproxen use: A case study and review of vismodegib safety. Int J Dermatol. 2015;54:370-374. [PMID: 25039741 DOI: 10.1111/ijd.12543] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
441 Stankov K, Sabo A, Mikov M. Pharmacogenetic Biomarkers as Tools for Pharmacoepidemiology of Severe Adverse Drug Reactions: Pharmacogenetics of Adverse Drug Reactions. Drug Dev Res 2013;74:1-14. [DOI: 10.1002/ddr.21050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
442 Kaur S, Kumar P, Kumar V, Sarin SK, Kumar A. Etiology and prognostic factors of acute liver failure in children. Indian Pediatr 2013;50:677-9. [PMID: 23255683 DOI: 10.1007/s13312-013-0189-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
443 Devarbhavi H, Aithal G, Treeprasertsuk S, Takikawa H, Mao Y, Shasthry SM, Hamid S, Tan SS, Philips CA, George J, Jafri W, Sarin SK; Asia Pacific Association of Study of Liver. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines. Hepatol Int 2021;15:258-82. [PMID: 33641080 DOI: 10.1007/s12072-021-10144-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
444 Lim CC, Tan HK. An Introduction to Extracorporeal Blood Purification in Critical Illness. Proceedings of Singapore Healthcare 2012;21:109-19. [DOI: 10.1177/201010581202100204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
445 Shah I, Vyas N, Reynolds JA. Natural Killer-Like T-Cell Lymphoma: A Rare Cause of Acute Liver Failure. ACG Case Rep J 2019;6:e00145. [PMID: 31620542 DOI: 10.14309/crj.0000000000000145] [Reference Citation Analysis]
446 Polson J, Wians FH Jr, Orsulak P, Fuller D, Murray NG, Koff JM, Khan AI, Balko JA, Hynan LS, Lee WM; Acute Liver Failure Study Group. False positive acetaminophen concentrations in patients with liver injury. Clin Chim Acta 2008;391:24-30. [PMID: 18279672 DOI: 10.1016/j.cca.2008.01.018] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
447 Gopi M, Seshadri MS. Biphasic Effect of Rifampicin on Bilirubin- A Case Report. J Clin Diagn Res 2016;10:OD14-5. [PMID: 27190870 DOI: 10.7860/JCDR/2016/18040.7614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
448 Amacher DE. Female gender as a susceptibility factor for drug-induced liver injury. Hum Exp Toxicol. 2014;33:928-939. [PMID: 24299907 DOI: 10.1177/0960327113512860] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
449 Haque T, Sasatomi E, Hayashi PH. Drug-Induced Liver Injury: Pattern Recognition and Future Directions. Gut Liver 2016;10:27-36. [PMID: 26696029 DOI: 10.5009/gnl15114] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
450 Bircsak KM, DeBiasio R, Miedel M, Alsebahi A, Reddinger R, Saleh A, Shun T, Vernetti LA, Gough A. A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®. Toxicology 2021;450:152667. [PMID: 33359578 DOI: 10.1016/j.tox.2020.152667] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
451 Betten DP, Vohra RB, Cook MD, Matteucci MJ, Clark RF. Antidote Use in the Critically Ill Poisoned Patient. J Intensive Care Med 2006;21:255-77. [DOI: 10.1177/0885066606290386] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 6.6] [Reference Citation Analysis]
452 Redwood AJ, Pavlos RK, White KD, Phillips EJ. HLAs: Key regulators of T-cell-mediated drug hypersensitivity. HLA 2018;91:3-16. [PMID: 29171940 DOI: 10.1111/tan.13183] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 20.0] [Reference Citation Analysis]
453 de Ataide EC, Reges Perales S, Bastos Eloy da Costa L, Valerini FG, Shiyoiti Hirano E, Chueiri Neto F, Silveira Bello Stucchi R, de Fátima Santana Ferreira Boin I. Acute Liver Failure-25 Years at a Single Center: Role of Liver Transplantation in the Survival of Adult Patients. Transplant Proc 2018;50:472-5. [PMID: 29579830 DOI: 10.1016/j.transproceed.2018.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
454 Humayun F, Shehab TM, Tworek JA, Fontana RJ. A fatal case of bupropion (Zyban) hepatotoxicity with autoimmune features: Case report. J Med Case Rep. 2007;1:88. [PMID: 17877816 DOI: 10.1186/1752-1947-1-88] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
455 Thanapirom K, Treeprasertsuk S, Soonthornworasiri N, Poovorawan K, Chaiteerakij R, Komolmit P, Phaosawasdi K, Pinzani M. The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study. BMC Gastroenterol 2019;19:18. [PMID: 30691414 DOI: 10.1186/s12876-019-0935-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
456 Shone LP, King JP, Doane C, Wilson KM, Wolf MS. Misunderstanding and potential unintended misuse of acetaminophen among adolescents and young adults. J Health Commun 2011;16 Suppl 3:256-67. [PMID: 21951256 DOI: 10.1080/10810730.2011.604384] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
457 Kim JD, Choi JY, Park C, Song MJ, Jang JW, Bae SH, Yoon SK, Lee YS, You YK, Kim DG. Clinical features of patients with fulminant hepatitis A requiring emergency liver transplantation: comparison with acute liver failure due to other causes. Korean J Hepatol 2010;16:19. [DOI: 10.3350/kjhep.2010.16.1.19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
458 Cao M, Wang L, Zhang L, Duan J. Global publication trends and hotspots of molecular biomarkers in DILI from 1991 to 2020: A 30-year bibliometric analysis. Sci Prog 2021;104:368504211000535. [PMID: 33749405 DOI: 10.1177/00368504211000535] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
459 Davern TJ. Indeterminate acute liver failure: A riddle wrapped in a mystery inside an enigma. Hepatology 2006;44:765-8. [DOI: 10.1002/hep.21305] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
460 Hughes TB, Swamidass SJ. Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism. Chem Res Toxicol 2017;30:642-56. [PMID: 28099803 DOI: 10.1021/acs.chemrestox.6b00385] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]
461 Williams DP, Shipley R, Ellis MJ, Webb S, Ward J, Gardner I, Creton S. Novel in vitro and mathematical models for the prediction of chemical toxicity. Toxicol Res (Camb) 2013;2:40-59. [PMID: 26966512 DOI: 10.1039/c2tx20031g] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
462 Bansod S, Saifi MA, Godugu C. Molecular updates on berberine in liver diseases: Bench to bedside. Phytother Res 2021. [PMID: 34056769 DOI: 10.1002/ptr.7181] [Reference Citation Analysis]
463 Kubo K, Kimura N, Mabe K, Matsuda S, Tsuda M, Kato M. Acute liver failure associated with diffuse large B-cell lymphoma: an autopsy case report. Clin J Gastroenterol 2020;13:1213-8. [PMID: 31919674 DOI: 10.1007/s12328-019-01091-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
464 Devarbhavi H, Singh R, Adarsh CK, Sheth K, Kiran R, Patil M. Factors that predict mortality in children with Wilson disease associated acute liver failure and comparison of Wilson disease specific prognostic indices. J Gastroenterol Hepatol. 2014;29:380-386. [PMID: 24033813 DOI: 10.1111/jgh.12356] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
465 Khandelwal N, James LP, Sanders C, Larson AM, Lee WM; Acute Liver Failure Study Group. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology 2011;53:567-76. [PMID: 21274877 DOI: 10.1002/hep.24060] [Cited by in Crossref: 112] [Cited by in F6Publishing: 87] [Article Influence: 11.2] [Reference Citation Analysis]
466 Ichai P, Samuel D. Management of Fulminant Hepatitis B. Curr Infect Dis Rep 2019;21:25. [PMID: 31165271 DOI: 10.1007/s11908-019-0682-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
467 Yang R, Yang F, Huang Z, Jin Y, Sheng Y, Ji L. Serum microRNA-122-3p, microRNA-194-5p and microRNA-5099 are potential toxicological biomarkers for the hepatotoxicity induced by Airpotato yam. Toxicology Letters 2017;280:125-32. [DOI: 10.1016/j.toxlet.2017.08.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
468 Maheshwari R, Subramanian RM. On the Brink of Death: Managing Acute Liver Failure. American Journal of Gastroenterology 2017;112:200-6. [DOI: 10.1038/ajg.2016.556] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
469 Segedi M, Dhani G, Ng VL, Grant D. Living Donors for Fulminant Hepatic Failure in Children. In: Greenberg RA, Goldberg AM, Rodríguez-arias D, editors. Ethical Issues in Pediatric Organ Transplantation. Cham: Springer International Publishing; 2016. pp. 19-41. [DOI: 10.1007/978-3-319-29185-7_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
470 Feng Y, Cui R, Li Z, Zhang X, Jia Y, Zhang X, Shi J, Qu K, Liu C, Zhang J. Methane Alleviates Acetaminophen-Induced Liver Injury by Inhibiting Inflammation, Oxidative Stress, Endoplasmic Reticulum Stress, and Apoptosis through the Nrf2/HO-1/NQO1 Signaling Pathway. Oxid Med Cell Longev 2019;2019:7067619. [PMID: 31781345 DOI: 10.1155/2019/7067619] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
471 Xiong QF, Xiong T, Huang P, Zhong YD, Wang HL, Yang YF. Early predictors of acute hepatitis B progression to liver failure. PLoS One 2018;13:e0201049. [PMID: 30048531 DOI: 10.1371/journal.pone.0201049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
472 Suzuki Y, Kakisaka K, Sato T, Mikami R, Abe H, Sasaki T, Takikawa Y. Tc-99m GSA scintigraphy within the first 3 days after admission as an early predictor of outcome in severe acute liver injury. Sci Rep 2021;11:12518. [PMID: 34131241 DOI: 10.1038/s41598-021-92058-6] [Reference Citation Analysis]
473 Need AC, Goldstein DB. Whole genome association studies in complex diseases: where do we stand? Dialogues Clin Neurosci 2010;12:37-46. [PMID: 20373665 [PMID: 20373665 DOI: 10.31887/dcns.2010.12.1/aneed] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
474 Achterbergh R, Lammers LA, Kuijsten L, Klümpen HJ, Mathôt RAA, Romijn JA. Effects of nutritional status on acetaminophen measurement and exposure. Clinical Toxicology 2019;57:42-9. [DOI: 10.1080/15563650.2018.1487563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
475 Navarro MED, Yao CC, Whiteley A, Movahedi B, Devuni D, Barry C, Zacharias I, Theodoropoulos NM, Bozorgzadeh A, Martins PN. Liver transplant evaluation for fulminant liver failure due to acute hepatitis A infection: Case series and literature review. Transpl Infect Dis. 2021;23:e13476. [PMID: 32989849 DOI: 10.1111/tid.13476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
476 Das P, Jain D, Das A. A retrospective autopsy study of histopathologic spectrum and etiologic trend of fulminant hepatic failure from north India. Diagn Pathol 2007;2:27. [PMID: 17662118 DOI: 10.1186/1746-1596-2-27] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
477 Cortez E, Boulger C, Bernard A. Ban Tu Wan hepatotoxicity. BMJ Case Rep 2012;2012:bcr2012006438. [PMID: 22878995 DOI: 10.1136/bcr-2012-006438] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
478 Yeoman AD, Westbrook RH, Zen Y, Maninchedda P, Portmann BC, Devlin J, O'Grady JG, Harrison PM, Heneghan MA. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. Hepatology. 2011;53:926-934. [PMID: 21374663 DOI: 10.1002/hep.24141] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 6.8] [Reference Citation Analysis]
479 Koch DG, Speiser JL, Durkalski V, Fontana RJ, Davern T, McGuire B, Stravitz RT, Larson AM, Liou I, Fix O, Schilsky ML, McCashland T, Hay JE, Murray N, Shaikh OS, Ganger D, Zaman A, Han SB, Chung RT, Brown RS, Munoz S, Reddy KR, Rossaro L, Satyanarayana R, Hanje AJ, Olson J, Subramanian RM, Karvellas C, Hameed B, Sherker AH, Lee WM, Reuben A. The Natural History of Severe Acute Liver Injury. Am J Gastroenterol 2017;112:1389-96. [PMID: 28440304 DOI: 10.1038/ajg.2017.98] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 12.5] [Reference Citation Analysis]
480 Ghabril M, Fontana R, Rockey D, Jiezhun G, Chalasani N. Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience. J Clin Gastroenterol. 2013;47:553-558. [PMID: 23388845 DOI: 10.1097/mcg.0b013e318276bf00] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
481 Pievsky D, Rustgi N, Pyrsopoulos NT. Classification and Epidemiologic Aspects of Acute Liver Failure. Clin Liver Dis 2018;22:229-41. [PMID: 29605063 DOI: 10.1016/j.cld.2018.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
482 Giordano C, Rivas J, Zervos X. An Update on Treatment of Drug-Induced Liver Injury. J Clin Transl Hepatol 2014;2:74-9. [PMID: 26356645 DOI: 10.14218/JCTH.2014.00005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
483 Amano T, Matsubara T, Nishida T, Shimakoshi H, Shimoda A, Sugimoto A, Takahashi K, Mukai K, Yamamoto M, Hayashi S, Nakajima S, Fukui K, Inada M. Clinically diagnosed late-onset fulminant Wilson’s disease without cirrhosis: A case report. World J Gastroenterol 2018; 24(2): 290-296 [PMID: 29375214 DOI: 10.3748/wjg.v24.i2.290] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
484 Tan EH, Ling ZJ, Ang PS, Sung C, Dan YY, Tai BC. Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilance. Pharmacoepidemiol Drug Saf 2020;29:1480-8. [PMID: 32844466 DOI: 10.1002/pds.5099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
485 Wei G, Bergquist A, Broomé U, Lindgren S, Wallerstedt S, Almer S, Sangfelt P, Danielsson Å, Sandberg-gertzén H, Lööf L, Prytz H, Björnsson E. Acute liver failure in Sweden: etiology and outcome. J Intern Med 2007;262:393-401. [DOI: 10.1111/j.1365-2796.2007.01818.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 84] [Article Influence: 7.7] [Reference Citation Analysis]
486 Devarbhavi H. Acute Liver Failure Induced by Anti-infectious Drugs: Causes and Management. Curr Hepatology Rep 2017;16:276-85. [DOI: 10.1007/s11901-017-0367-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
487 Jalan R. Acute liver failure: current management and future prospects. J Hepatol. 2005;42 Suppl:S115-S123. [PMID: 15777566 DOI: 10.1016/j.jhep.2004.11.010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
488 Louvet A, Ntandja Wandji LC, Lemaître E, Khaldi M, Lafforgue C, Artru F, Quesnel B, Lassailly G, Dharancy S, Mathurin P. Acute Liver Injury With Therapeutic Doses of Acetaminophen: A Prospective Study. Hepatology 2021;73:1945-55. [PMID: 33306215 DOI: 10.1002/hep.31678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
489 Urban TJ, Nicoletti P, Chalasani N, Serrano J, Stolz A, Daly AK, Aithal GP, Dillon J, Navarro V, Odin J, Barnhart H, Ostrov D, Long N, Cirulli ET, Watkins PB, Fontana RJ; Drug-Induced Liver Injury Network (DILIN)., Pharmacogenetics of Drug-Induced Liver Injury group (DILIGEN)., International Serious Adverse Events Consortium (iSAEC). Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor. J Hepatol 2017;67:137-44. [PMID: 28323125 DOI: 10.1016/j.jhep.2017.03.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 17.0] [Reference Citation Analysis]
490 Fujiwara K, Yasui S, Nakano M, Yonemitsu Y, Arai M, Kanda T, Fukuda Y, Oda S, Yokosuka O. Severe and fulminant hepatitis of indeterminate etiology in a Japanese center: Acute liver failure of indeterminate etiology. Hepatol Res 2015;45:E141-9. [DOI: 10.1111/hepr.12483] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
491 Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, French NS, Dhaun N, Webb DJ, Costello EM. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology. 2011;54:1767-1776. [PMID: 22045675 DOI: 10.1002/hep.24538] [Cited by in Crossref: 379] [Cited by in F6Publishing: 350] [Article Influence: 42.1] [Reference Citation Analysis]
492 Tsutsui A, Nakanuma Y, Takaguchi K, Nakamura S, Shibata H, Baba N, Senoh T, Nagano T, Ikeda H. Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury. Mediators Inflamm. 2015;2015:913793. [PMID: 26783385 DOI: 10.1155/2015/913793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
493 Duffy J, Padovani F, Brunetti G, Noy P, Certa U, Hegner M. Towards personalised rapid label free miRNA detection for cancer and liver injury diagnostics in cell lysates and blood based samples. Nanoscale 2018;10:12797-804. [PMID: 29947396 DOI: 10.1039/c8nr03604g] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
494 Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe’er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet. 2009;41:816-819. [PMID: 19483685 DOI: 10.1038/ng.379] [Cited by in Crossref: 749] [Cited by in F6Publishing: 607] [Article Influence: 62.4] [Reference Citation Analysis]
495 Kalsi SS, Wood DM, Waring WS, Dargan PI. Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose? Open Access Emerg Med 2011;3:69-76. [PMID: 27147854 DOI: 10.2147/OAEM.S24962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
496 Bleibel W, Kim S, D’silva K, Lemmer ER. Drug-Induced Liver Injury: Review Article. Dig Dis Sci 2007;52:2463-71. [DOI: 10.1007/s10620-006-9472-y] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 5.1] [Reference Citation Analysis]
497 Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology. 2008;47:1401-1415. [PMID: 18318440 DOI: 10.1002/hep.22177] [Cited by in Crossref: 442] [Cited by in F6Publishing: 388] [Article Influence: 34.0] [Reference Citation Analysis]
498 Green TJ, Sivilotti ML, Langmann C, Yarema M, Juurlink D, Burns MJ, Johnson DW. When do the aminotransferases rise after acute acetaminophen overdose? Clinical Toxicology 2010;48:787-92. [DOI: 10.3109/15563650.2010.523828] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
499 Verma A, Lilienfeld DE. The need for a population-based surveillance system for liver disease in the United States. Pharmacoepidemiol Drug Saf 2004;13:821-4. [PMID: 15486959 DOI: 10.1002/pds.1022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
500 Shaw PJ, Ganey PE, Roth RA. Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure. J Pharmacol Exp Ther 2009;328:62-8. [PMID: 18820134 DOI: 10.1124/jpet.108.143792] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
501 Burroughs A, McNamara D. Liver disease in Europe. Aliment Pharmacol Ther. 2003;18 Suppl 3:54-59. [PMID: 14531742 DOI: 10.1046/j.0953-0673.2003.01729.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
502 Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podestá LG, Villamil FG. MELD is superior to King’s college and Clichy’s criteria to assess prognosis in fulminant hepatic failure. Liver Transpl. 2007;13:822-828. [PMID: 17539002 DOI: 10.1002/lt.21104] [Cited by in Crossref: 123] [Cited by in F6Publishing: 97] [Article Influence: 8.8] [Reference Citation Analysis]
503 Rutter K, Horvatits T, Drolz A, Roedl K, Siedler S, Kluge S, Fuhrmann V. [Acute liver failure]. Wien Klin Mag 2019;22:38-47. [PMID: 32288865 DOI: 10.1007/s00740-018-0243-0] [Reference Citation Analysis]
504 Schilsky ML. Acute liver failure and liver assist devices. Transplant Proc 2011;43:879-83. [PMID: 21486619 DOI: 10.1016/j.transproceed.2011.01.109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
505 Shumar J, Ordway S, Junga Z, Sadowski B, Torres D. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM). ACG Case Rep J 2019;6:e00184. [PMID: 31737715 DOI: 10.14309/crj.0000000000000184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
506 Björnsson ES. Epidemiology, Predisposing Factors, and Outcomes of Drug-Induced Liver Injury. Clin Liver Dis 2020;24:1-10. [PMID: 31753242 DOI: 10.1016/j.cld.2019.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
507 Lewis JH. 'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective. Pharmacoepidemiol Drug Saf 2006;15:221-9. [PMID: 16444771 DOI: 10.1002/pds.1209] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
508 Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, Duseja A, Chawla Y. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King’s College Hospital criteria. Liver Transpl. 2007;13:814-821. [PMID: 17370333 DOI: 10.1002/lt.21050] [Cited by in Crossref: 97] [Cited by in F6Publishing: 75] [Article Influence: 6.9] [Reference Citation Analysis]
509 Steadman RH. Anesthesia for liver transplant surgery. Anesthesiol Clin North America. 2004;22:687-711. [PMID: 15541931 DOI: 10.1016/j.atc.2004.06.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
510 Meng X, Li Y, Li S, Gan R, Li H. Natural Products for Prevention and Treatment of Chemical-Induced Liver Injuries: Chemical-induced liver injuries…. Comprehensive Reviews in Food Science and Food Safety 2018;17:472-95. [DOI: 10.1111/1541-4337.12335] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 11.3] [Reference Citation Analysis]
511 Schiødt FV, Ostapowicz G, Murray N, Satyanarana R, Zaman A, Munoz S, Lee WM; Acute Liver Failure Study Group. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl 2006;12:1776-81. [DOI: 10.1002/lt.20886] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 5.0] [Reference Citation Analysis]
512 Kramer L. Acute liver failure. Wien Klin Wochenschr. 2004;116:67-81. [PMID: 15008314 DOI: 10.1007/bf03040699] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
513 Hayashi PH, Rockey DC, Fontana RJ, Tillmann HL, Kaplowitz N, Barnhart HX, Gu J, Chalasani NP, Reddy KR, Sherker AH, Hoofnagle JH;  Drug-Induced Liver Injury Network (DILIN) Investigators. Death and liver transplantation within 2 years of onset of drug-induced liver injury. Hepatology. 2017;66:1275-1285. [PMID: 28543844 DOI: 10.1002/hep.29283] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 12.3] [Reference Citation Analysis]
514 Allison JJ, Saag KG. Unbalanced regulation of over-the-counter analgesics: the lesser of two evils? Pharmacoepidem Drug Safe 2006;15:410-1. [DOI: 10.1002/pds.1227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
515 Jia R, Oda S, Yokoi T. Pharmacological evidence for the involvement of ryanodine receptors in halothane-induced liver injury in mice. Toxicology 2020;443:152560. [PMID: 32795494 DOI: 10.1016/j.tox.2020.152560] [Reference Citation Analysis]
516 Shaw PJ, Ganey PE, Roth RA. Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity. Toxicol Sci 2010;118:7-18. [PMID: 20538741 DOI: 10.1093/toxsci/kfq168] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 7.6] [Reference Citation Analysis]
517 Gow P, Hathaway M, Gunson B, Heward J, Mutimer D. Association of fulminant non-A non-B hepatitis with homozygosity for HLA A1-B8-DR3. J Gastroenterol Hepatol 2005;20:555-61. [DOI: 10.1111/j.1440-1746.2005.03605.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
518 Atienzar FA, Blomme EA, Chen M, Hewitt P, Kenna JG, Labbe G, Moulin F, Pognan F, Roth AB, Suter-Dick L, Ukairo O, Weaver RJ, Will Y, Dambach DM. Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans. Biomed Res Int 2016;2016:9737920. [PMID: 27689095 DOI: 10.1155/2016/9737920] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
519 Tan YL, Ho HK. Hypothermia Advocates Functional Mitochondria and Alleviates Oxidative Stress to Combat Acetaminophen-Induced Hepatotoxicity. Cells 2020;9:E2354. [PMID: 33114500 DOI: 10.3390/cells9112354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
520 Lorincz MT. Wilson disease and related copper disorders. Neurogenetics, Part I. Elsevier; 2018. pp. 279-92. [DOI: 10.1016/b978-0-444-63233-3.00018-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 7.3] [Reference Citation Analysis]
521 Lee WM. Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away? J Hepatol. 2017;67:1324-1331. [PMID: 28734939 DOI: 10.1016/j.jhep.2017.07.005] [Cited by in Crossref: 112] [Cited by in F6Publishing: 98] [Article Influence: 28.0] [Reference Citation Analysis]
522 Björnsson E, Kalaitzakis E, Av Klinteberg V, Alem N, Olsson R. Long-term follow-up of patients with mild to moderate drug-induced liver injury. Aliment Pharmacol Ther 2007;26:79-85. [PMID: 17555424 DOI: 10.1111/j.1365-2036.2007.03355.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
523 Yu JW, Sun LJ, Yan BZ, Kang P, Zhao YH. Lamivudine treatment is associated with improved survival in fulminant hepatitis B. Liver Int 2011;31:499-506. [PMID: 21382160 DOI: 10.1111/j.1478-3231.2011.02450.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
524 Richards JA, Bucsaiova M, Hesketh EE, Ventre C, Henderson NC, Simpson K, Bellamy CO, Howie SE, Anderton SM, Hughes J, Wigmore SJ. Acute Liver Injury Is Independent of B Cells or Immunoglobulin M. PLoS One 2015;10:e0138688. [PMID: 26406765 DOI: 10.1371/journal.pone.0138688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
525 Hwang S, Lee SG, Park JI, Song GW, Ryu JH, Jung DH, Hwang GS, Jeong SM, Song JG, Hong SK. Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation. Clin Transplant. 2010;24:91-97. [PMID: 19925461 DOI: 10.1111/j.1399-0012.2009.01148.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
526 Urban TJ, Goldstein DB, Watkins PB. Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here? Pharmacogenomics 2012;13:735-8. [PMID: 22594502 DOI: 10.2217/pgs.12.45] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
527 Weaver RJ, Blomme EA, Chadwick AE, Copple IM, Gerets HHJ, Goldring CE, Guillouzo A, Hewitt PG, Ingelman-sundberg M, Jensen KG, Juhila S, Klingmüller U, Labbe G, Liguori MJ, Lovatt CA, Morgan P, Naisbitt DJ, Pieters RHH, Snoeys J, van de Water B, Williams DP, Park BK. Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models. Nat Rev Drug Discov 2020;19:131-48. [DOI: 10.1038/s41573-019-0048-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 24.0] [Reference Citation Analysis]
528 Chen M, Borlak J, Tong W. High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology. 2013;58:388-396. [PMID: 23258593 DOI: 10.1002/hep.26208] [Cited by in Crossref: 207] [Cited by in F6Publishing: 172] [Article Influence: 25.9] [Reference Citation Analysis]
529 Kaplowitz N. Drug-Induced Liver Injury. Drug-Induced Liver Disease. Elsevier; 2013. pp. 3-14. [DOI: 10.1016/b978-0-12-387817-5.00001-7] [Cited by in Crossref: 26] [Article Influence: 3.3] [Reference Citation Analysis]
530 Overby CL, Pathak J, Gottesman O, Haerian K, Perotte A, Murphy S, Bruce K, Johnson S, Talwalkar J, Shen Y, Ellis S, Kullo I, Chute C, Friedman C, Bottinger E, Hripcsak G, Weng C. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc 2013;20:e243-52. [PMID: 23837993 DOI: 10.1136/amiajnl-2013-001930] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
531 Yang J, Sun H, Liu Q. The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2016;2016:5802674. [PMID: 27148364 DOI: 10.1155/2016/5802674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
532 Devarbhavi H, Dierkhising R, Kremers WK, Sandeep MS, Karanth D, Adarsh CK. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol. 2010;105:2396-2404. [PMID: 20648003 DOI: 10.1038/ajg.2010.287] [Cited by in Crossref: 133] [Cited by in F6Publishing: 114] [Article Influence: 12.1] [Reference Citation Analysis]
533 Li L, Wang H, Zhang J, Sha Y, Wu F, Wen S, He L, Sheng L, You Q, Shi M, Liu L, Zhou H. SPHK1 deficiency protects mice from acetaminophen-induced ER stress and mitochondrial permeability transition. Cell Death Differ 2020;27:1924-37. [PMID: 31827236 DOI: 10.1038/s41418-019-0471-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
534 Cardoso FS, Pereira R, Moreno R, Karvellas CJ, Germano N. Optic Nerve Sheath Diameter in Acute Liver Failure: A Prospective Cohort Study. GE Port J Gastroenterol 2021;28:170-8. [PMID: 34056039 DOI: 10.1159/000511646] [Reference Citation Analysis]
535 Miyake Y, Iwasaki Y, Terada R, Onishi T, Okamoto R, Sakai N, Sakaguchi K, Shiratori Y. Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases. Aliment Pharmacol Ther. 2006;23:1347-1353. [PMID: 16629940 DOI: 10.1111/j.1365-2036.2006.02894.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
536 Park YM, Lee BH, Lee HJ, Kang SG. Cholestatic jaundice induced by duloxetine in a patient with major depressive disorder. Psychiatry Investig 2010;7:228-30. [PMID: 20927314 DOI: 10.4306/pi.2010.7.3.228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
537 Schmidt LE, Dalhoff K. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology. 2005;41:26-31. [PMID: 15690478 DOI: 10.1002/hep.20511] [Cited by in Crossref: 103] [Cited by in F6Publishing: 83] [Article Influence: 6.4] [Reference Citation Analysis]
538 Andrade RJ, Lucena MI, Kaplowitz N, García-Muņoz B, Borraz Y, Pachkoria K, García-Cortés M, Fernández MC, Pelaez G, Rodrigo L, Durán JA, Costa J, Planas R, Barriocanal A, Guarner C, Romero-Gomez M, Muņoz-Yagüe T, Salmerón J, Hidalgo R. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology 2006;44:1581-8. [PMID: 17133470 DOI: 10.1002/hep.21424] [Cited by in Crossref: 197] [Cited by in F6Publishing: 167] [Article Influence: 14.1] [Reference Citation Analysis]
539 Elinav E, Ben-Dov I, Hai-Am E, Ackerman Z, Ofran Y. The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy. J Hepatol. 2005;42:82-86. [PMID: 15629511 DOI: 10.1016/j.jhep.2004.09.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
540 Shapiro MA, Lewis JH. Causality Assessment of Drug-Induced Hepatotoxicity: Promises and Pitfalls. Clinics in Liver Disease 2007;11:477-505. [DOI: 10.1016/j.cld.2007.06.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 74] [Article Influence: 6.5] [Reference Citation Analysis]
541 Cui Y, Paules RS. Use of transcriptomics in understanding mechanisms of drug-induced toxicity. Pharmacogenomics 2010;11:573-85. [PMID: 20350139 DOI: 10.2217/pgs.10.37] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 7.0] [Reference Citation Analysis]
542 Escorsell À, Mas A, de la Mata M; Spanish Group for the Study of Acute Liver Failure. Acute liver failure in Spain: Analysis of 267 cases. Liver Transpl 2007;13:1389-95. [DOI: 10.1002/lt.21119] [Cited by in Crossref: 128] [Cited by in F6Publishing: 98] [Article Influence: 9.1] [Reference Citation Analysis]
543 Di Giorgio A, Nicastro E, Dalla Rosa D, Nebbia G, Sonzogni A, D'Antiga L. Transplant-free Survival in Chronic Liver Disease Presenting as Acute Liver Failure in Childhood. Transplantation 2019;103:544-51. [PMID: 30028785 DOI: 10.1097/TP.0000000000002367] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
544 Palomo L, Mleczko JE, Azkargorta M, Conde-Vancells J, González E, Elortza F, Royo F, Falcon-Perez JM. Abundance of Cytochromes in Hepatic Extracellular Vesicles Is Altered by Drugs Related With Drug-Induced Liver Injury. Hepatol Commun 2018;2:1064-79. [PMID: 30202821 DOI: 10.1002/hep4.1210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
545 Amar PJ, Schiff ER. Acetaminophen safety and hepatotoxicity--where do we go from here? Expert Opin Drug Saf 2007;6:341-55. [PMID: 17688378 DOI: 10.1517/14740338.6.4.341] [Cited by in Crossref: 70] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
546 Billioti de Gage S, Collin C, Le-Tri T, Pariente A, Bégaud B, Verdoux H, Dray-Spira R, Zureik M. Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database. CNS Drugs 2018;32:673-84. [PMID: 29959758 DOI: 10.1007/s40263-018-0537-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
547 Brown SA, Axenfeld E, Stonesifer EG, Hutson W, Hanish S, Raufman J, Urrunaga NH. Current and prospective therapies for acute liver failure. Disease-a-Month 2018;64:493-522. [DOI: 10.1016/j.disamonth.2018.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
548 King JP, Davis TC, Bailey SC, Jacobson KL, Hedlund LA, Di Francesco L, Parker RM, Wolf MS. Developing consumer-centered, nonprescription drug labeling a study in acetaminophen. Am J Prev Med 2011;40:593-8. [PMID: 21565649 DOI: 10.1016/j.amepre.2011.02.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
549 Yang Y, Zhong Z, Ding Y, Zhang W, Ma Y, Zhou L. Bioinformatic identification of key genes and pathways that may be involved in the pathogenesis of HBV-associated acute liver failure. Genes Dis 2018;5:349-57. [PMID: 30591937 DOI: 10.1016/j.gendis.2018.02.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
550 Hunt CM, Papay JI, Stanulovic V, Regev A. Drug rechallenge following drug-induced liver injury. Hepatology 2017;66:646-54. [PMID: 28295448 DOI: 10.1002/hep.29152] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
551 Mullen RJ, Curtis LM, O'Conor R, Serper M, McCarthy D, Bailey SC, Parker RM, Wolf MS. Visual acuity, literacy, and unintentional misuse of nonprescription medications. Am J Health Syst Pharm 2018;75:e213-20. [PMID: 29691264 DOI: 10.2146/ajhp170303] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
552 Murphy D, Khan A, Borscheid C, Riad S. A quarter pound of acetaminophen with propylene glycol on the side: A case report. Clin Nephrol Case Stud 2020;8:62-6. [PMID: 32905357 DOI: 10.5414/CNCS109936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
553 Bushel PR, Fannin RD, Gerrish K, Watkins PB, Paules RS. Blood gene expression profiling of an early acetaminophen response. Pharmacogenomics J 2017;17:230-6. [PMID: 26927286 DOI: 10.1038/tpj.2016.8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
554 Court MH, Freytsis M, Wang X, Peter I, Guillemette C, Hazarika S, Duan SX, Greenblatt DJ, Lee WM; Acute Liver Failure Study Group. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure. J Pharmacol Exp Ther 2013;345:297-307. [PMID: 23408116 DOI: 10.1124/jpet.112.202010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
555 Weber S, Benesic A, Rotter I, Gerbes AL. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis. Liver Int 2019;39:1906-17. [PMID: 31319011 DOI: 10.1111/liv.14195] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
556 Bunchorntavakul C, Reddy KR. Acetaminophen-related hepatotoxicity. Clin Liver Dis. 2013;17:587-607, viii. [PMID: 24099020 DOI: 10.1016/j.cld.2013.07.005] [Cited by in Crossref: 134] [Cited by in F6Publishing: 116] [Article Influence: 16.8] [Reference Citation Analysis]
557 Mainardi V, Rando K, Valverde M, Olivari D, Castelli J, Rey G, Gerona S. Acute Liver Failure due to Wilson Disease: Eight Years of the National Liver Transplant Program in Uruguay. Ann Hepatol. 2019;18:187-192. [PMID: 31113589 DOI: 10.5604/01.3001.0012.7911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
558 Ghanem CI, Manautou JE. Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics. Curr Med Chem 2019;26:1185-223. [PMID: 29473496 DOI: 10.2174/0929867325666180221142315] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
559 Hunt CM, Yuen NA, Stirnadel-Farrant HA, Suzuki A. Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database. Regul Toxicol Pharmacol. 2014;70:519-526. [PMID: 25236535 DOI: 10.1016/j.yrtph.2014.09.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
560 Goldaracena N, Spetzler VN, Marquez M, Selzner N, Cattral MS, Greig PD, Lilly L, Mcgilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, Selzner M. Live Donor Liver Transplantation: A Valid Alternative for Critically Ill Patients Suffering From Acute Liver Failure: Live Donor Transplant for Acute Liver Failure. American Journal of Transplantation 2015;15:1591-7. [DOI: 10.1111/ajt.13203] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
561 Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson’s disease. Lancet. 2007;369:397-408. [PMID: 17276780 DOI: 10.1016/s0140-6736(07)60196-2] [Cited by in Crossref: 660] [Cited by in F6Publishing: 197] [Article Influence: 47.1] [Reference Citation Analysis]
562 Björnsson E, Jerlstad P, Bergqvist A, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scandinavian Journal of Gastroenterology 2009;40:1095-101. [DOI: 10.1080/00365520510023846] [Cited by in Crossref: 94] [Cited by in F6Publishing: 72] [Article Influence: 7.8] [Reference Citation Analysis]
563 Lakshmi T, Sri Renukadevi B, Senthilkumar S, Haribalan P, Parameshwari R, Vijayaraghavan R, Rajeshkumar S. Seed and bark extracts of Acacia catechu protects liver from acetaminophen induced hepatotoxicity by modulating oxidative stress, antioxidant enzymes and liver function enzymes in Wistar rat model. Biomed Pharmacother 2018;108:838-44. [PMID: 30372895 DOI: 10.1016/j.biopha.2018.08.077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
564 Huang W, Whittaker K, Zhang H, Wu J, Zhu S, Huang R. Integration of Antibody Array Technology into Drug Discovery and Development. ASSAY and Drug Development Technologies 2018;16:74-95. [DOI: 10.1089/adt.2017.808] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
565 Wei G, Kalaitzakis E, Bergquist A, Björnsson E. Long-term follow-up of patients with acute liver failure of indeterminate aetiology. Scand J Gastroenterol 2008;43:984-91. [PMID: 19086167 DOI: 10.1080/00365520801965399] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
566 Hassan A, Fontana RJ. The diagnosis and management of idiosyncratic drug-induced liver injury. Liver Int. 2019;39:31-41. [PMID: 30003672 DOI: 10.1111/liv.13931] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
567 Levitsky J, Duddempudi AT, Lakeman FD, Whitley RJ, Luby JP, Lee WM, Fontana RJ, Blei AT, Ison MG; US Acute Liver Failure Study Group. Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure. Liver Transpl. 2008;14:1498-1504. [PMID: 18825709 DOI: 10.1002/lt.21567] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
568 García-cortés M, Andrade R, Lucena M, González-grande R, Camargo R, Fernández-bonilla E, Martos J, Alcántara R. Hepatotoxicidad secundaria a fármacos de uso común. Gastroenterología y Hepatología 2005;28:461-72. [DOI: 10.1157/13079002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
569 Vasikasin V, Rojdumrongrattana T, Chuerboonchai W, Siriwiwattana T, Thongtaeparak W, Niyasom S, Lertliewtrakool N, Jitsiri S, Changpradub D. Effect of standard dose paracetamol versus placebo as antipyretic therapy on liver injury in adult dengue infection: a multicentre randomised controlled trial. Lancet Glob Health 2019;7:e664-70. [PMID: 31000133 DOI: 10.1016/S2214-109X(19)30032-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
570 Yang H, Li SQ, Wang SL, Song Y, Cheng WG, Wang Y, Zhang BB, Wang DM, Wang YL. Comparison of the Effects of Intraperitoneal Injection with Carbon Tetrachloride on Acute Liver Toxicity in Male and Female Kunming Mice. Med Sci Monit 2021;27:e931427. [PMID: 34366426 DOI: 10.12659/MSM.931427] [Reference Citation Analysis]
571 Miyake Y, Iwasaki Y, Terada R, Takaguchi K, Sakaguchi K, Shiratori Y. Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B. J Gastroenterol. 2007;42:485-492. [PMID: 17671764 DOI: 10.1007/s00535-007-2029-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
572 Jung DH, Hwang S, Lim YS, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Park GC, Lee SG. Outcome comparison of liver transplantation for hepatitis A-related vs hepatitis B-related acute liver failure in adult recipients. Clin Transplant. 2018;32. [PMID: 29044729 DOI: 10.1111/ctr.13140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
573 Serper M, Wolf MS, Parikh NA, Tillman H, Lee WM, Ganger DR. Risk Factors, Clinical Presentation, and Outcomes in Overdose With Acetaminophen Alone or With Combination Products: Results From the Acute Liver Failure Study Group. J Clin Gastroenterol 2016;50:85-91. [PMID: 26166142 DOI: 10.1097/MCG.0000000000000378] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
574 Xia Q, Zhao Y, Lin G, Beland FA, Cai L, Fu PP. Pyrrolizidine Alkaloid-Protein Adducts: Potential Non-invasive Biomarkers of Pyrrolizidine Alkaloid-Induced Liver Toxicity and Exposure. Chem Res Toxicol 2016;29:1282-92. [DOI: 10.1021/acs.chemrestox.6b00120] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
575 Wong A, Graudins A. N-acetylcysteine regimens for paracetamol overdose: Time for a change?: N-acetylcysteine for Paracetamol Overdose. Emergency Medicine Australasia 2016;28:749-51. [DOI: 10.1111/1742-6723.12610] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
576 Shamseddeen H, Vilar-Gomez E, Chalasani N, Myers RP, Subramanian GM, Shlevin HH, Allgood AE, Orman ES. Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring. Drug Saf 2020;43:281-90. [PMID: 31907854 DOI: 10.1007/s40264-019-00896-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
577 Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179-1197. [PMID: 15841455 DOI: 10.1002/hep.20703] [Cited by in Crossref: 603] [Cited by in F6Publishing: 503] [Article Influence: 37.7] [Reference Citation Analysis]
578 Liu C, Fan H, Li Y, Xiao X. Research Advances on Hepatotoxicity of Herbal Medicines in China. Biomed Res Int 2016;2016:7150391. [PMID: 28078299 DOI: 10.1155/2016/7150391] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
579 Lee WM. Acetaminophen Toxicity: A History of Serendipity and Unintended Consequences. Clin Liver Dis (Hoboken) 2020;16:34-44. [PMID: 33042525 DOI: 10.1002/cld.984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
580 McMillin M, Grant S, Frampton G, Andry S, Brown A, DeMorrow S. Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice. J Neuroinflammation. 2016;13:198. [PMID: 27561705 DOI: 10.1186/s12974-016-0674-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
581 Bell LN, Vuppalanchi R, Watkins PB, Bonkovsky HL, Serrano J, Fontana RJ, Wang M, Rochon J, Chalasani N. Serum proteomic profiling in patients with drug-induced liver injury. Aliment Pharmacol Ther. 2012;35:600-612. [PMID: 22403816 DOI: 10.1111/j.1365-2036.2011.04982.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
582 Istúriz RE, Torres J, Besso J. Global distribution of infectious diseases requiring intensive care. Crit Care Clin 2006;22:469-88, ix. [PMID: 16893734 DOI: 10.1016/j.ccc.2006.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
583 van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008;47:1634-1643. [PMID: 18395843 DOI: 10.1002/hep.22236] [Cited by in Crossref: 366] [Cited by in F6Publishing: 351] [Article Influence: 28.2] [Reference Citation Analysis]
584 Altyar A, Kordi L, Skrepnek G. Clinical and economic characteristics of emergency department visits due to acetaminophen toxicity in the USA. BMJ Open 2015;5:e007368. [PMID: 26353865 DOI: 10.1136/bmjopen-2014-007368] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
585 Feld JJ, Liang TJ. Hepatitis C — identifying patients with progressive liver injury. Hepatology 2006;43:S194-206. [DOI: 10.1002/hep.21065] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 4.2] [Reference Citation Analysis]
586 Zaky HS, Gad AM, Nemr E, Hassan W, Abd El-Raouf OM, Ali AA. Modulatory effects of some natural products on hepatotoxicity induced by combination of sodium valproate and paracetamol in rats. J Biochem Mol Toxicol 2018;:e22162. [PMID: 29799656 DOI: 10.1002/jbt.22162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
587 Zhang J, Zhang L, Sun X, Yang Y, Kong L, Lu C, Lv G, Wang T, Wang H, Fu F. Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment Ameliorate Acetaminophen-Induced Liver Injury in Mice via Central Cholinergic System Regulation. J Pharmacol Exp Ther 2016;359:374-82. [PMID: 27535978 DOI: 10.1124/jpet.116.233841] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
588 Ng S, Han R, Chang S, Ni J, Hunziker W, Goryachev AB, Ong SH, Yu H. Improved hepatocyte excretory function by immediate presentation of polarity cues. Tissue Eng 2006;12:2181-91. [PMID: 16968159 DOI: 10.1089/ten.2006.12.2181] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
589 Han MK, Hyzy R. Advances in critical care management of hepatic failure and insufficiency: . Critical Care Medicine 2006;34:S225-31. [DOI: 10.1097/01.ccm.0000231882.85350.71] [Cited by in Crossref: 40] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
590 Watkins PB, Seligman PJ, Pears JS, Avigan MI, Senior JR. Using controlled clinical trials to learn more about acute drug-induced liver injury. Hepatology 2008;48:1680-9. [PMID: 18853438 DOI: 10.1002/hep.22633] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 6.2] [Reference Citation Analysis]
591 Aminoshariae A, Khan A. Acetaminophen: old drug, new issues. J Endod 2015;41:588-93. [PMID: 25732401 DOI: 10.1016/j.joen.2015.01.024] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 9.2] [Reference Citation Analysis]
592 Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914-928. [PMID: 24389305 DOI: 10.1053/j.gastro.2013.12.032] [Cited by in Crossref: 147] [Cited by in F6Publishing: 130] [Article Influence: 18.4] [Reference Citation Analysis]
593 Tischer S, Fontana RJ. Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting. J Hepatol 2014;60:872-84. [PMID: 24280292 DOI: 10.1016/j.jhep.2013.11.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
594 Alempijevic T, Zec S, Milosavljevic T. Drug-induced liver injury: Do we know everything? World J Hepatol 2017; 9(10): 491-502 [PMID: 28443154 DOI: 10.4254/wjh.v9.i10.491] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
595 Nikkilä K, Nissinen MJ, Gylling H, Isoniemi H, Miettinen TA. Serum sterols in patients with primary biliary cirrhosis and acute liver failure before and after liver transplantation. J Hepatol. 2008;49:936-945. [PMID: 18926587 DOI: 10.1016/j.jhep.2008.07.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
596 Pannu AK, Bhalla A, Rao C, Singh C. Delta model for end-stage liver disease and delta clinical prognostic indicator as predictors of mortality in patients with viral acute liver failure. Int J Crit Illn Inj Sci 2017;7:252-5. [PMID: 29291180 DOI: 10.4103/IJCIIS.IJCIIS_122_16] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
597 Jiang F, Yan H, Liang L, Du J, Jin S, Yang S, Wang H, Hu T, Zhu Y, Wang G, Hu Y, Cai T, Aithal GP. Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): Large cohort study involving 4652 Chinese adult tuberculosis patients. Liver Int 2021;41:1565-75. [PMID: 33866661 DOI: 10.1111/liv.14896] [Reference Citation Analysis]
598 Singhal S, Jain S, Kohaar I, Singla M, Gondal R, Kar P. Apoptotic Mechanisms in Fulminant Hepatic Failure: Potential Therapeutic Target. Applied Immunohistochemistry & Molecular Morphology 2009;17:282-5. [DOI: 10.1097/pai.0b013e3181906f6d] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
599 Poulsen KL, Albee RP, Ganey PE, Roth RA. Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase. J Pharmacol Exp Ther 2014;349:185-91. [PMID: 24525298 DOI: 10.1124/jpet.113.211276] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
600 Bai L, Liu X, Zheng Q, Kong M, Zhang X, Hu R, Lou J, Ren F, Chen Y, Zheng S, Liu S, Han YP, Duan Z, Pandol SJ. M2-like macrophages in the fibrotic liver protect mice against lethal insults through conferring apoptosis resistance to hepatocytes. Sci Rep 2017;7:10518. [PMID: 28874845 DOI: 10.1038/s41598-017-11303-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
601 Rosenblatt R, Brown RS. Nonviral or Drug-Induced Etiologies of Acute Liver Failure. Clinics in Liver Disease 2018;22:347-60. [DOI: 10.1016/j.cld.2018.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
602 Gunawan BK, Kaplowitz N. Mechanisms of drug-induced liver disease. Clin Liver Dis. 2007;11:459-475, v. [PMID: 17723915 DOI: 10.1016/j.cld.2007.06.001] [Cited by in Crossref: 107] [Cited by in F6Publishing: 84] [Article Influence: 7.6] [Reference Citation Analysis]
603 Aleo MD, Luo Y, Swiss R, Bonin PD, Potter DM, Will Y. Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology. 2014;60:1015-1022. [PMID: 24799086 DOI: 10.1002/hep.27206] [Cited by in Crossref: 150] [Cited by in F6Publishing: 123] [Article Influence: 21.4] [Reference Citation Analysis]
604 Stine JG, Sateesh P, Lewis JH. Drug-induced liver injury in the elderly. Curr Gastroenterol Rep. 2013;15:299. [PMID: 23250699 DOI: 10.1007/s11894-012-0299-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
605 Zhao ZW, Chang JC, Lin LW, Tsai FH, Chang HC, Wu CR. Comparison of the Hepatoprotective Effects of Four Endemic Cirsium Species Extracts from Taiwan on CCl₄-Induced Acute Liver Damage in C57BL/6 Mice. Int J Mol Sci 2018;19:E1329. [PMID: 29710853 DOI: 10.3390/ijms19051329] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
606 Baig M, Wool KJ, Halanych JH, Sarmad RA. Acute Liver Failure after Initiation of Rivaroxaban: A Case Report and Review of the Literature. N Am J Med Sci 2015;7:407-10. [PMID: 26605205 DOI: 10.4103/1947-2714.166221] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
607 Tsien MZ, Cordova J, Qadir A, Zhao L, Hart J, Azzam R. Topiramate-Induced Acute Liver Failure in a Pediatric Patient: a Case Report and Review of Literature. Journal of Pediatric Gastroenterology & Nutrition 2016;63:e37-8. [DOI: 10.1097/mpg.0000000000000566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
608 Petronijevic M, Ilic K. Associations of gender and age with the reporting of drug-induced hepatic failure: data from the VigiBase™. J Clin Pharmacol. 2013;53:435-443. [PMID: 23440959 DOI: 10.1002/jcph.3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
609 Kang SH, Kim JI, Jeong KH, Ko KH, Ko PG, Hwang SW, Kim EM, Kim SH, Lee HY, Lee BS. [Clinical characteristics of 159 cases of acute toxic hepatitis]. Korean J Hepatol. 2008;14:483-492. [PMID: 19119243 DOI: 10.3350/kjhep.2008.14.4.483] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
610 Chang A, Krygier DS, Chatur N, Yoshida EM. Clozapine-induced fatal fulminant hepatic failure: a case report. Can J Gastroenterol 2009;23:376-8. [PMID: 19440569 DOI: 10.1155/2009/503916] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
611 Thomas AM, Lewis JH. Nonacetaminophen Drug-Induced Acute Liver Failure. Clinics in Liver Disease 2018;22:301-24. [DOI: 10.1016/j.cld.2018.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
612 Gunawan B, Kaplowitz N. Clinical Perspectives on Xenobiotic‐Induced Hepatotoxicity. Drug Metabolism Reviews 2004;36:301-12. [DOI: 10.1081/dmr-120034148] [Cited by in Crossref: 69] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
613 Tung D, Yoshida EM, Wang CS, Steinbrecher UP. Severe desflurane hepatotoxicity after colon surgery in an elderly patient. Can J Anaesth. 2005;52:133-136. [PMID: 15684251 DOI: 10.1007/bf03027717] [Cited by in Crossref: 33] [Cited by in F6Publishing: 3] [Article Influence: 2.1] [Reference Citation Analysis]
614 Bell LN, Chalasani N. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis. 2009;29:337-347. [PMID: 19826967 DOI: 10.1055/s-0029-1240002] [Cited by in Crossref: 126] [Cited by in F6Publishing: 105] [Article Influence: 10.5] [Reference Citation Analysis]
615 Xu D, Wu M, Nishimura S, Nishimura T, Michie SA, Zheng M, Yang Z, Yates AJ, Day JS, Hillgren KM. Chimeric TK-NOG mice: a predictive model for cholestatic human liver toxicity. J Pharmacol Exp Ther. 2015;352:274-280. [PMID: 25424997 DOI: 10.1124/jpet.114.220798] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
616 Yu L, Zhao XK, Cheng ML, Yang GZ, Wang B, Liu HJ, Hu YX, Zhu LL, Zhang S, Xiao ZW, Liu YM, Zhang BF, Mu M. Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury. Sci Rep 2017;7:1359. [PMID: 28465509 DOI: 10.1038/s41598-017-01271-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
617 Akamatsu N, Sugawara Y, Kokudo N. Acute liver failure and liver transplantation. Intractable Rare Dis Res 2013;2:77-87. [PMID: 25343108 DOI: 10.5582/irdr.2013.v2.3.77] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
618 Gonzalez FJ. The 2006 Bernard B. Brodie Award Lecture. Cyp2e1. Drug Metab Dispos. 2007;35:1-8. [PMID: 17020953 DOI: 10.1124/dmd.106.012492] [Cited by in Crossref: 152] [Cited by in F6Publishing: 137] [Article Influence: 10.1] [Reference Citation Analysis]
619 Roberts EA. “Not so rare” Wilson disease. Clinics and Research in Hepatology and Gastroenterology 2013;37:219-21. [DOI: 10.1016/j.clinre.2013.03.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
620 Guo JJ, Wigle PR, Lammers K, Vu O. Comparison of potentially hepatotoxic drugs among major US drug compendia. Research in Social and Administrative Pharmacy 2005;1:460-79. [DOI: 10.1016/j.sapharm.2005.06.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
621 Shi X, Xu H, Ji W, Liang Y, Duan W, He L, Wang M, Zhao Z. Efficacy of liver transplantation for acute hepatic failure: a single-center experience. Hepatobiliary & Pancreatic Diseases International 2011;10:369-73. [DOI: 10.1016/s1499-3872(11)60062-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
622 George N, Jose A, Dharamsi S, Venkatakrishnan L, Mathew AC. Prognostic Survival Factors in Acute Liver Failure Patients in India. Adv Biomed Res 2020;9:37. [PMID: 33072649 DOI: 10.4103/abr.abr_70_19] [Reference Citation Analysis]
623 Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 2012;3:56. [PMID: 23091461 DOI: 10.3389/fphys.2012.00056] [Cited by in Crossref: 141] [Cited by in F6Publishing: 146] [Article Influence: 15.7] [Reference Citation Analysis]
624 Abid A, Subhani F, Kayani F, Awan S, Abid S. Drug induced liver injury is associated with high mortality-A study from a tertiary care hospital in Pakistan. PLoS One 2020;15:e0231398. [PMID: 32276267 DOI: 10.1371/journal.pone.0231398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
625 Petronijevic M, Ilic K, Suzuki A. Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database: REPORTING OF HEPATOTOXICITY IN SERBIA. Pharmacoepidem Drug Safe 2011;20:416-23. [DOI: 10.1002/pds.2115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
626 Borlak J, Chatterji B, Londhe KB, Watkins PB. Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injury. Genome Med 2013;5:86. [PMID: 24070255 DOI: 10.1186/gm493] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
627 Taylor RM, Tujios S, Jinjuvadia K, Davern T, Shaikh OS, Han S, Chung RT, Lee WM, Fontana RJ. Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis. Dig Dis Sci. 2012;57:777-785. [PMID: 21948394 DOI: 10.1007/s10620-011-1918-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
628 Sivilotti ML, Yarema MC, Juurlink DN, Good AM, Johnson DW. A Risk Quantification Instrument for Acute Acetaminophen Overdose Patients Treated With N-Acetylcysteine. Annals of Emergency Medicine 2005;46:263-71. [DOI: 10.1016/j.annemergmed.2005.04.004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
629 Jemnitz K, Veres Z, Monostory K, Kóbori L, Vereczkey L. Interspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytes. Toxicol In Vitro 2008;22:961-7. [PMID: 18346862 DOI: 10.1016/j.tiv.2008.02.001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
630 Eslami V, Gheymati A. Clopidogrel-induced liver damage: A case report and review of the literature. Clin Case Rep 2020;8:3024-7. [PMID: 33363872 DOI: 10.1002/ccr3.3324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
631 Zheng N, Gu Y, Hong Y, Sheng L, Chen L, Zhang F, Hou J, Zhang W, Zhang Z, Jia W, Li H. Vancomycin pretreatment attenuates acetaminophen-induced liver injury through 2-hydroxybutyric acid. J Pharm Anal 2020;10:560-70. [PMID: 33425450 DOI: 10.1016/j.jpha.2019.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
632 Das R, Mitra S, Tareq AM, Emran TB, Hossain MJ, Alqahtani AM, Alghazwani Y, Dhama K, Simal-Gandara J. Medicinal plants used against hepatic disorders in Bangladesh: A comprehensive review. J Ethnopharmacol 2022;282:114588. [PMID: 34480997 DOI: 10.1016/j.jep.2021.114588] [Reference Citation Analysis]
633 Baudy AR, Otieno MA, Hewitt P, Gan J, Roth A, Keller D, Sura R, Van Vleet TR, Proctor WR. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry. Lab Chip 2020;20:215-25. [DOI: 10.1039/c9lc00768g] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 31.0] [Reference Citation Analysis]
634 Andrade RJ, Camargo R, Lucena MI, González-Grande R. Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf. 2004;3:329-344. [PMID: 15268650 DOI: 10.1517/14740338.3.4.329] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
635 Gandhi D, Ahuja K, Quade A, Batts KP, Patel L. Kratom induced severe cholestatic liver injury histologically mimicking primary biliary cholangitis: A case report. World J Hepatol 2020; 12(10): 863-869 [PMID: 33200023 DOI: 10.4254/wjh.v12.i10.863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
636 Wong NZ, Reddy KR, Bittermann T. Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort. Liver Transpl 2021. [PMID: 34081838 DOI: 10.1002/lt.26187] [Reference Citation Analysis]
637 Kartiko S, Ortiz J, Hashemi N, Miick R, Dallal R. Acute liver failure complicating jejunojejunal intussusception presentation in a gastric bypass patient. World J Hepatol 2012; 4(11): 311-313 [PMID: 23293717 DOI: 10.4254/wjh.v4.i11.311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
638 Kon K, Ikejima K, Okumura K, Arai K, Aoyama T, Watanabe S. Diabetic KK-A y mice are highly susceptible to oxidative hepatocellular damage induced by acetaminophen. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010;299:G329-37. [DOI: 10.1152/ajpgi.00361.2009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
639 Li J, Zhu X, Liu F, Cai P, Sanders C, Lee WM, Uetrecht J. Cytokine and autoantibody patterns in acute liver failure. J Immunotoxicol. 2010;7:157-164. [PMID: 20039781 DOI: 10.3109/15476910903501748] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
640 Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010;1184:173-87. [PMID: 20146697 DOI: 10.1111/j.1749-6632.2009.05109.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 119] [Article Influence: 16.4] [Reference Citation Analysis]
641 Lin K, Lin AN, Linn S, Hlaing PP, Vasudevan V, Reddy M. Ginseng-Related Drug-Induced Liver Injury. Case Rep Gastroenterol 2018;12:439-46. [PMID: 30186097 DOI: 10.1159/000490525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
642 Grande RG, Pérez MJ. Liver Transplantation in Acute Liver Failure: Indications and Outcome. In: Rodrigo L, editor. Liver Research and Clinical Management. InTech; 2018. [DOI: 10.5772/intechopen.72664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
643 Bhamidimarri KR, Schiff E. Drug-induced cholestasis. Clin Liver Dis. 2013;17:519-531, vii. [PMID: 24099015 DOI: 10.1016/j.cld.2013.07.015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
644 Lee WM. Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol. 2012;26:3-16. [PMID: 22482521 DOI: 10.1016/j.bpg.2012.01.014] [Cited by in Crossref: 69] [Cited by in F6Publishing: 51] [Article Influence: 8.6] [Reference Citation Analysis]
645 Weinstein RB, Schuemie MJ, Ryan PB, Stang PE. Seasonality in acute liver injury? Findings in two health care claims databases. Drug Healthc Patient Saf 2016;8:39-48. [PMID: 27099532 DOI: 10.2147/DHPS.S95399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
646 Chia AJ, Goldring CE, Kitteringham NR, Wong SQ, Morgan P, Park BK. Differential effect of covalent protein modification and glutathione depletion on the transcriptional response of Nrf2 and NF-kappaB. Biochem Pharmacol 2010;80:410-21. [PMID: 20416283 DOI: 10.1016/j.bcp.2010.04.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
647 Ronan BA, Agrwal N, Carey EJ, De Petris G, Kusne S, Seville MT, Blair JE, Vikram HR. Fulminant hepatitis due to human adenovirus. Infection. 2014;42:105-111. [PMID: 23979854 DOI: 10.1007/s15010-013-0527-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
648 Butler DC, Lewin DN, Batalis NI. Differential Diagnosis of Hepatic Necrosis Encountered at Autopsy. Acad Forensic Pathol 2018;8:256-95. [PMID: 31240042 DOI: 10.1177/1925362118782056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
649 Pathikonda M, Munoz SJ. Acute Liver Failure. Annals of Hepatology 2010;9:7-14. [DOI: 10.1016/s1665-2681(19)31673-4] [Cited by in Crossref: 26] [Article Influence: 2.4] [Reference Citation Analysis]
650 Chojkier M. Troglitazone and liver injury: In search of answers. Hepatology 2005;41:237-46. [DOI: 10.1002/hep.20567] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 5.3] [Reference Citation Analysis]
651 Huo M. New oral anticoagulants in venous thromboembolism prophylaxis in orthopaedic patients: Are they really better? Thromb Haemost 2017;106:45-57. [DOI: 10.1160/th10-10-0653] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
652 Abdelmegeed MA, Moon KH, Chen C, Gonzalez FJ, Song BJ. Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity. Biochem Pharmacol 2010;79:57-66. [PMID: 19660437 DOI: 10.1016/j.bcp.2009.07.016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 4.6] [Reference Citation Analysis]
653 Khan SA, Shah N, Williams R, Jalan R. Acute liver failure: a review. Clin Liver Dis 2006;10:239-58, vii-viii. [PMID: 16971260 DOI: 10.1016/j.cld.2006.05.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
654 Lu BR, Gralla J, Liu E, Dobyns EL, Narkewicz MR, Sokol RJ. Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure. Clin Gastroenterol Hepatol. 2008;6:1140-1145. [PMID: 18928939 DOI: 10.1016/j.cgh.2008.05.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
655 Gahr M, Zeiss R, Lang D, Connemann BJ, Hiemke C, Schönfeldt-lecuona C. Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms. The Journal of Clinical Pharmacology 2016;56:769-78. [DOI: 10.1002/jcph.662] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
656 McPhail MJ, Farne H, Senvar N, Wendon JA, Bernal W. Ability of King's College Criteria and Model for End-Stage Liver Disease Scores to Predict Mortality of Patients With Acute Liver Failure: A Meta-analysis. Clin Gastroenterol Hepatol 2016;14:516-525.e5; quiz e43-e45. [PMID: 26499930 DOI: 10.1016/j.cgh.2015.10.007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 10.8] [Reference Citation Analysis]
657 Kulkarni S, Perez C, Pichardo C, Castillo L, Gagnon M, Beck-sague C, Gereige R, Hernandez E. Use of Pediatric Health Information System database to study the trends in the incidence, management, etiology, and outcomes due to pediatric acute liver failure in the United States from 2008 to 2013. Pediatr Transplantation 2015;19:888-95. [DOI: 10.1111/petr.12596] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
658 Fernandes CT, Iqbal U, Tighe SP, Ahmed A. Kratom-Induced Cholestatic Liver Injury and Its Conservative Management. J Investig Med High Impact Case Rep. 2019;7:2324709619836138. [PMID: 30920318 DOI: 10.1177/2324709619836138] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
659 Lee WM. Liver: determining prognosis in acute liver failure. Nat Rev Gastroenterol Hepatol 2012;9:192-4. [PMID: 22392292 DOI: 10.1038/nrgastro.2012.34] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
660 Wang Y, Xie X, Liu H, Liu H, Jiang H. LR12 Promotes Liver Repair by Improving the Resolution of Inflammation and Liver Regeneration in Mice with Thioacetamide- (TAA-) Induced Acute Liver Failure. Mediators Inflamm 2021;2021:2327721. [PMID: 34135689 DOI: 10.1155/2021/2327721] [Reference Citation Analysis]
661 Novak D, Lewis JH. Drug-induced liver disease: . Current Opinion in Gastroenterology 2003;19:203-15. [DOI: 10.1097/00001574-200305000-00004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
662 Rajekar H, Wai CT, Majeed TA, Lee KH, Wong SY, Leong SO, Singh R, Tay KH, Soosaynathan C, Tan KC. Prognostic factors in patients with acute liver failure undergoing live donor liver transplantation. Transplant Proc. 2008;40:2492-2493. [PMID: 18929776 DOI: 10.1016/j.transproceed.2008.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
663 Dabos KJ, Newsome PN, Parkinson JA, Davidson JS, Sadler IH, Plevris JN, Hayes PC. A biochemical prognostic model of outcome in paracetamol-induced acute liver injury. Transplantation. 2005;80:1712-1717. [PMID: 16378066 DOI: 10.1097/01.tp.0000187879.51616.e0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
664 Kalgutkar AS. Designing around Structural Alerts in Drug Discovery. J Med Chem 2020;63:6276-302. [PMID: 31497963 DOI: 10.1021/acs.jmedchem.9b00917] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
665 Singhal A, Neuberger J. Acute liver failure: Bridging to transplant or recovery– are we there yet? Journal of Hepatology 2007;46:557-64. [DOI: 10.1016/j.jhep.2007.01.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
666 Knudsen TT, Thorsen S, Jensen SA, Dalhoff K, Schmidt LE, Becker U, Bendtsen F. Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects. Gut 2005;54:515-21. [PMID: 15753537 DOI: 10.1136/gut.2004.043505] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
667 Fujiwara K, Yasui S, Tawada A, Okitsu K, Yonemitsu Y, Chiba T, Arai M, Kanda T, Imazeki F, Nakano M. Autoimmune fulminant liver failure in adults: Experience in a Japanese center. Hepatol Res. 2011;41:133-141. [PMID: 21269383 DOI: 10.1111/j.1872-034x.2010.00755.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
668 Yeoman AD, Westbrook RH, Zen Y, Bernal W, Al-Chalabi T, Wendon JA, O'Grady JG, Heneghan MA. Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome. J Hepatol 2014;61:876-82. [PMID: 24842305 DOI: 10.1016/j.jhep.2014.05.021] [Cited by in Crossref: 88] [Cited by in F6Publishing: 74] [Article Influence: 12.6] [Reference Citation Analysis]
669 Randesi M, Levran O, Correa da Rosa J, Hankins J, Rule J, Kreek MJ, Lee WM; Acute Liver Failure Study Group. Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury. Cell Mol Gastroenterol Hepatol 2017;3:500-5. [PMID: 28462386 DOI: 10.1016/j.jcmgh.2017.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
670 Rutherford AE, Hynan LS, Borges CB, Forcione DG, Blackard JT, Lin W, Gorman AR, Shaikh OS, Reuben A, Harrison E. Serum apoptosis markers in acute liver failure: a pilot study. Clin Gastroenterol Hepatol. 2007;5:1477-1483. [PMID: 17967565 DOI: 10.1016/j.cgh.2007.08.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
671 Dai C, Ma S, Wang F, Zhao H, Wu X, Huang Z, Chen Z, To K, Fu L. Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes. Oncotarget 2015;6:17738-52. [PMID: 26036634 DOI: 10.18632/oncotarget.3921] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
672 Huang X, Shao L, Gong Y, Mao Y, Liu C, Qu H, Cheng Y. A metabonomic characterization of CCl4-induced acute liver failure using partial least square regression based on the GC/MS metabolic profiles of plasma in mice. J Chromatogr B Analyt Technol Biomed Life Sci 2008;870:178-85. [PMID: 18602877 DOI: 10.1016/j.jchromb.2008.05.049] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
673 Kakisaka K, Takikawa Y. Elevation of serum cytokines preceding elevation of liver enzymes in a case of drug-induced liver injury. Hepatol Res. 2013;44:E284-E289. [PMID: 24119001 DOI: 10.1111/hepr.12253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
674 Rutherford A, Davern T, Hay JE, Murray NG, Hassanein T, Lee WM, Chung RT. Influence of high body mass index on outcome in acute liver failure. Clin Gastroenterol Hepatol. 2006;4:1544-1549. [PMID: 16996806 DOI: 10.1016/j.cgh.2006.07.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
675 Lv H, Liu L, Zhang Y, Song T, Lu J, Chen X. Ingenuity pathways analysis of urine metabonomics phenotypes toxicity of gentamicin in multiple organs. Mol Biosyst 2010;6:2056-67. [PMID: 20714645 DOI: 10.1039/c0mb00064g] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
676 Chen M, Hong H, Fang H, Kelly R, Zhou G, Borlak J, Tong W. Quantitative Structure-Activity Relationship Models for Predicting Drug-Induced Liver Injury Based on FDA-Approved Drug Labeling Annotation and Using a Large Collection of Drugs. Toxicological Sciences 2013;136:242-9. [DOI: 10.1093/toxsci/kft189] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 7.6] [Reference Citation Analysis]
677 Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55-68. [PMID: 19132805 DOI: 10.2165/00002018-200932010-00005] [Cited by in Crossref: 286] [Cited by in F6Publishing: 254] [Article Influence: 23.8] [Reference Citation Analysis]
678 Carrascosa MF, Lucena MI, Andrade RJ, Caviedes JR, Lavín AC, Mones JC, Rivero AP, Serrano VB. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. Clin Ther 2009;31:1014-9. [PMID: 19539102 DOI: 10.1016/j.clinthera.2009.05.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
679 Totsugawa T, Yong C, Rivas-Carrillo JD, Soto-Gutierrez A, Navarro-Alvarez N, Noguchi H, Okitsu T, Westerman KA, Kohara M, Reth M. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination. J Hepatol. 2007;47:74-82. [PMID: 17434229 DOI: 10.1016/j.jhep.2007.02.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
680 Ananthakrishnan AN, Mcginley EL, Saeian K. Effect of hospital volume and teaching status on outcomes of acute liver failure. Liver Transpl 2008;14:1347-56. [DOI: 10.1002/lt.21519] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
681 Bari K, Fontana RJ. Acetaminophen overdose: what practitioners need to know. Clinical Liver Dis. 2014;4:17-21. [PMID: 30992913 DOI: 10.1002/cld.373] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
682 Vliegenthart ADB, Berends C, Potter CMJ, Kersaudy-Kerhoas M, Dear JW. MicroRNA-122 can be measured in capillary blood which facilitates point-of-care testing for drug-induced liver injury. Br J Clin Pharmacol 2017;83:2027-33. [PMID: 28257154 DOI: 10.1111/bcp.13282] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
683 Jafri SM, Singal AG, Kaul D, Fontana RJ. Detection and management of latent tuberculosis in liver transplant patients. Liver Transpl. 2011;17:306-314. [PMID: 21384513 DOI: 10.1002/lt.22203] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
684 Metushi IG, Hayes MA, Uetrecht J. Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients. Hepatology 2015;61:1332-42. [PMID: 25283142 DOI: 10.1002/hep.27549] [Cited by in Crossref: 89] [Cited by in F6Publishing: 77] [Article Influence: 14.8] [Reference Citation Analysis]
685 De Valle MB, Av Klinteberg V, Alem N, Olsson R, Björnsson E. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006;24:1187-1195. [PMID: 17014577 DOI: 10.1111/j.1365-2036.2006.03117.x] [Cited by in Crossref: 136] [Cited by in F6Publishing: 128] [Article Influence: 9.7] [Reference Citation Analysis]
686 Saccomano S, Deluca DA. Too toxic. Nursing Management 2008;39:32A-H. [DOI: 10.1097/01.numa.0000335258.54215.93] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
687 Uetrecht J. Immune-mediated adverse drug reactions. Chem Res Toxicol 2009;22:24-34. [PMID: 19149477 DOI: 10.1021/tx800389u] [Cited by in Crossref: 82] [Cited by in F6Publishing: 63] [Article Influence: 6.8] [Reference Citation Analysis]
688 Li W, Li Y, Jiang X, Li X, Yu Z. Compound Ammonium Glycyrrhizin Protects Hepatocytes from Injury Induced by Lipopolysaccharide/Florfenicol through a Mitochondrial Pathway. Molecules 2018;23:E2378. [PMID: 30227687 DOI: 10.3390/molecules23092378] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
689 Barber JB, Gibson SJ. Treatment of chronic non-malignant pain in the elderly: safety considerations. Drug Saf 2009;32:457-74. [PMID: 19459714 DOI: 10.2165/00002018-200932060-00003] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 6.3] [Reference Citation Analysis]
690 Kantola T, Koivusalo AM, Höckerstedt K, Isoniemi H. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients. Transpl Int. 2008;21:857-866. [PMID: 18510596 DOI: 10.1111/j.1432-2277.2008.00698.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
691 Wang HS, Han SB. Management of Hepatitis B in Special Patient Populations. Clinics in Liver Disease 2010;14:505-20. [DOI: 10.1016/j.cld.2010.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
692 Marrero J, Martinez FJ, Hyzy R. Advances in Critical Care Hepatology. Am J Respir Crit Care Med 2003;168:1421-6. [DOI: 10.1164/rccm.200303-361up] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 1.4]<